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Dynamin-related	protein	1	 (Drp1),	 the	main	mammalian	mediator	of	mitochondrial	 fission,	
has	an	especially	important	role	in	neuronal	development,	such	that	its	deletion	gives	rise	to	
pre-	or	perinatal	lethality.	However,	less	is	known	about	the	need	for	Drp1	in	adult	neurons;	
this	 is	 relevant	 because	 inhibition	 of	 Drp1	 could	 prevent	 pre-apoptotic	 mitochondrial	
fragmentation,	and	therefore	be	neuroprotective.	
In	our	mouse	model,	inducible	Drp1	ablation	in	the	forebrain	of	adult	mice	leads	to	swollen,	
perinuclearly	 aggregated	 mitochondria	 and	 to	 impaired	 synaptic	 transmission.	 Of	 note,	
ablated	mice	also	develop	a	complex	and	ultimately	lethal	catabolic	phenotype,	marked	by	
weight	 loss,	 increased	 lipolysis	 and	 elevated	 corticosterone.	 We	 traced	 this	 back	 to	 the	
activation	of	the	integrated	stress	response	in	Drp1-ablated	brain	regions,	culminating	in	the	
ectopic	 induction	of	metabolic	 cytokine	Fgf21.	Fgf21	 is	normally	produced	 in	 liver,	 fat	and	
muscle	tissue	in	response	to	fasting	or	exercise,	and	no	reports	exist	of	it	being	produced	in	
the	 brain.	 This	 “mitokine”	 increases	 insulin	 sensitivity	 and	 stimulates	 corticosterone	
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Mitochondria	 are	 the	 result	 of	 the	 engulfment,	 over	 1.5	 billion	 years	 ago,	 of	 an	 α-
proteobacterial	 ancestor	 by	 a	 larger	 host	 cell.	 This	 initiated	 a	 process	 of	 endosymbiosis	
(Margulis,	1975),	whereby	mitochondria	provided	the	host	cell	with	energy	and	metabolites,	
and	 in	exchange	surrendered	control	of	 their	 replication	and	morphology	to	the	host.	This	
was	 achieved	 via	 the	 transfer	 of	 most	 of	 the	 mitochondrion’s	 genetic	 material	 to	 the	
nucleus,	 leaving	 only	 a	 16-kilobase-long	 circular	 chromosome	 within	 the	 organelle.	 The	
mitochondrial	 genome	 (mtDNA)	 codes	 for	 a	 total	 of	 37	 genes,	 of	 which	 13	 are	 protein	
subunits	of	the	respiratory	chain,	22	are	mitochondria-specific	transfer	RNAs	(tRNAs)	and	2	
are	ribosomal	RNAs	(rRNAs).	The	remainder	of	the	estimated	1000	proteins	that	constitute	








(IMM),	which	 folds	 to	 form	membrane	 invaginations	 termed	 cristae.	 The	 two	membranes	
define	 two	 distinct	 compartments:	 the	 intermembrane	 space	 (IMS)	 between	 OMM	 and	
IMM;	and	the	matrix,	within	the	IMM.	
The	OMM	serves	as	both	a	barrier	–	albeit	a	poorly	selective	one	–	for	solutes,	metabolites	
and	 larger	 molecules,	 as	 well	 as	 a	 hub	 for	 interorganellar	 communication,	 mediating	









matrix-cytosol	 energy	 transfer,	 lipid	 transfer	 and	 in	 the	 relaying	 of	 apoptotic	 signals	
(Reichert	and	Neupert,	2002;	Tatsuta	et	al.,	2014).	
The	 IMM	 attachment	 to	 the	 OMM	 is	 interrupted	 by	 the	 cristae,	 deep	 IMM	 invaginations	
protruding	into	the	matrix	space.	The	cristae	are	enriched	in	proteins	and	protein	complexes	
that	 carry	 out	 biosynthetic	 and	 bioenergetic	 roles	 within	 mitochondria,	 foremost	 among	
them	respiratory	complexes	and	supercomplexes	(Cogliati	et	al.,	2013).	
The	cristae	compartment	is	physically	separated	from	the	rest	of	the	intermembrane	space	




maintain	 cristae	 morphology,	 such	 that	 their	 absence	 leads	 to	 massive	 cristae	
rearrangement	 and	 IMM	 stacking.	 The	 remaining	 four	 subunits	 (Aim5,	 Aim13,	 Aim37,	
Mio27)	are	 important	 for	mtDNA	 inheritance,	 suggesting	 that	 they	 interact	with	nucleoids	
(van	 der	 Laan	 et	 al.,	 2012).	 The	 MICOS	 complex	 interacts	 with	 both	 the	 protein	 import	





This	 classical	 textbook	 presentation	 of	 mitochondria	 as	 static	 organelles	 stems	 primarily	
from	electron	microscopy	(EM)	observations	on	fixed	tissues	(Palade,	1953);	nevertheless,	as	
early	 as	 1914,	 studies	on	 live	 cells	 had	 revealed	 that	mitochondria	 are,	 in	 fact,	 a	 dynamic	
network	that	is	able	to	fuse	and	divide	in	response	to	intra-	and	extracellular	cues	(Lewis	and	
Lewis,	1914).	The	processes	of	mitochondrial	fusion	and	fission	and	of	cristae	remodeling	are	





























3. A	 variable	 domain,	 which	 undergoes	 alternative	 splicing	 and	 harbors	 sites	 of	
posttranslational	modification.	




Given	 that	most	of	 a	 cell’s	Drp1	pool	 is	 cytosolic,	 recruitment	mechanisms	are	 in	place	 to	
activate	it	and	to	direct	it	to	mitochondria	in	order	to	mediate	fission	(Labrousse	et	al.,	1999;	
Smirnova	et	al.,	2001).	Mitochondrial	fission	articulates	in	three	steps:	(I)	the	selection	and	
marking	of	 a	prospective	 fission	 site;	 (II)	 the	assembly	of	 the	division	 complex	around	 the	
mitochondrial	 tubule;	 (III)	 the	 GTP-driven	 constriction	 that	 causes	 the	 severing	 of	 the	
mitochondrial	unit	into	two	daughters.	
	
The	 marking	 of	 the	 fission	 site	 initiates	 the	 division	 process	 by	 ensuring	 that	 the	
mitochondrial	 tubule,	normally	300-500	nm	 in	diameter,	constrict	 to	an	extent	compatible	
with	 the	120-nm	Drp1	helix.	 This	 is	 accomplished	by	 the	 ER	wrapping	 around	prospective	
fission	 sites	 on	 mitochondria	 (Friedman	 et	 al.,	 2011)	 in	 a	 process	 termed	 ER-associated	
mitochondrial	 division	 (ERMD).	 Additional	 support	 for	 mitochondrial	 tubule	 constriction	
comes	 from	 actin	 polymerization	 by	 the	 inverted	 formin	 INF2,	 followed	 by	 Myosin	 II	
recruitment	(Hatch	et	al.,	2014;	Korobova	et	al.,	2013);	this	is	further	supported	by	reports	
that	actin	destabilization	prevents	mitochondrial	fission	(Korobova	et	al.,	2013,	2014).	Other	







Given	 that	Drp1	does	not	harbor	membrane-interaction	domains,	 it	needs	 to	bind	protein	
adaptors	 on	 the	 OMM	 in	 order	 to	 exert	 its	 effects	 on	 mitochondria.	 In	 yeast,	 Drp1	
recruitment	to	mitochondria	is	accomplished	by	C-terminal-anchored	OMM	protein	Fis1	and	
adaptor	protein	Mdv1,	which	does	not	have	a	mammalian	ortholog.	In	mammals,	four	Drp1-
recruiting	 proteins	 have	 been	 identified	 so	 far:	 mitochondrial	 fission	 factor	 (Mff),	
mitochondrial	 dynamics	 proteins	 of	 49	 and	 51	 kDa	 (MiD49	 and	MiD51,	 also	 known	 as	
Mief1),	and	Fis1.	Of	note,	Fis1	 is	not	strictly	required	for	fission,	but	 its	knockdown	causes	
mitochondrial	 elongation	 and	 its	 overexpression	 fragments	 mitochondria	 (Gomes	 and	
Scorrano,	2008;	James	et	al.,	2003;	Koirala	et	al.,	2013;	Losón	et	al.,	2013;	Shen	et	al.,	2014).	
Mff	 is	 the	 main	 Drp1	 recruiter	 in	 basal	 condition,	 and	 it	 functions	 independently	 of	 Fis1	
(Gandre-Babbe	and	van	der	Bliek,	2008;	Losón	et	al.,	2013;	Otera	et	al.,	2010).	MiD49	and	
MiD51	are	both	able	 to	bind	Drp1,	but	 they	can	either	 sequester	 it	 in	an	 inactive	 form	or	






the	 fission	 capacity	 of	 Drp1:	 namely,	 Drp1	 can	 undergo	 phosphorylation,	 S-nitrosylation,	
ubiquitylation	 and	 SUMOylation	 (SUMO,	 small	 ubiquitin-like	modifier)	 (Oettinghaus	 et	 al.,	
2012;	Wilson	et	al.,	2013).	
Two	 serine	 residues,	 both	 located	 in	 the	 GTPase	 effector	 domain,	 can	 undergo	
phosphorylation.		
Protein	Kinase	A	 (PKA),	when	activated	by	high	 levels	of	cyclic	adenosine	monophosphate	
(cAMP),	 phosphorylates	 Drp1	 on	 Ser637,	 resulting	 in	 the	 inhibition	 of	 its	 fission	 activity	
(Chang	 and	 Blackstone,	 2007;	 Cribbs	 and	 Strack,	 2007),	 possibly	 by	 interfering	 with	 helix	
assembly	 (Cereghetti	 et	 al.,	 2008).	 The	 same	 residue	 can	 also	 be	 phosphorylated	 by	




phosphorylated	 Ser637	 can	 be	 targeted	 by	 phosphatase	 calcineurin,	 resulting	 in	 an	
enhancement	 of	 Drp1	 fission	 activity	 (Cereghetti	 et	 al.,	 2008).	 In	 neurons,	 protein	
phosphatase	2A	(PP2A)	is	also	able	to	dephosphorylate	Ser637	(Dickey	and	Strack,	2011).	
Phosphorylation	of	Drp1	in	Ser616	by	the	Cdk1/CyclinB	complex	exerts	the	opposite	effect	
of	 Ser637,	 promoting	 rather	 than	 inhibiting	 mitochondrial	 fission	 (Taguchi	 et	 al.,	 2007).	
Protein	 Kinase	 C	δ 	 (PKCδ)	has	also	been	 reported	 to	 target	Ser616	 for	phosphorylation	 in	
neurons	(Qi	et	al.,	2011),	though	the	relevance	of	this	process	for	physiological	contexts	has	





phosphorylation	 when	 the	 cell	 undergoes	 starvation;	 this	 causes	 mitochondrial	 network	
hyperfusion,	which	 protects	mitochondria	 from	macroautophagy	 in	 order	 to	 preserve	 the	
cell’s	 ATP-producing	 abilities	 (Gomes	 et	 al.,	 2011);	 on	 the	 other	 hand,	 elimination	 of	 the	




Drp1	 can	 also	 undergo	 S-nitrosylation	 on	 a	 conserved	 cysteine	 residue	 in	 the	 GTPase	
effector	 domain	 (Barsoum	 et	 al.,	 2006;	 Cho	 et	 al.,	 2009).	 This	 leads	 to	 an	 increase	 in	
mitochondrial	 fission,	possibly	by	enhancing	the	effects	of	Drp1-activating	phosphorylation	
(Bossy	et	al.,	2010).	
In	 addition,	 ubiquitylation	 can	modulate	Drp1	 function.	Ubiquitin	 E3	 ligase	MARCH5	 (also	
known	as	MITOL)	can	ubiquitylate	Drp1	and	MiD49,	modulating	mitochondrial	morphology	




Finally,	 SUMO	 can	 be	 covalently	 attached	 to	 Drp1,	 rendering	 it	more	 stable	 at	 the	OMM	





et	 al.,	 2004),	 while	 the	 removal	 of	 the	 SUMO	moieties	 is	 performed	 by	 SUMO	 protease	
SenP5	(Zunino	et	al.,	2007).	Of	note,	Drp1	stabilization	by	MAPL-mediated	SUMOylation	has	




Following	 recruitment	 to	 the	OMM,	Drp1	 self-assembles	 in	 a	GTP-dependent	manner	 into	
helical	 structures	 that	wrap	 around	 ER-marked	mitochondrial	 tubules;	 together	with	 actin	
and	the	ER,	the	assembly	of	the	Drp1	helix	further	constricts	the	mitochondrion	(Lackner	et	






independent	 mitochondrial	 fragmentation	 during	 apoptosis,	 bacterial	 infection	 or	 with	
specific	mutations	of	α-synuclein	(Guardia-Laguarta	et	al.,	2014;	Ishihara	et	al.,	2009;	Stavru	
et	al.,	2013);	furthermore,	Drp1-deficient	mouse	embryonic	fibroblasts	(MEFs)	are	still	able	
to	 partition	 their	 mitochondria	 during	 cell	 division	 (Pernas	 and	 Scorrano,	 2015).	 This	





Mitochondrial	 fusion	 is	 essential	 to	 maintain	 the	 overall	 health	 of	 the	 mitochondrial	
network;	indeed,	fusion	allows	for	the	dilution	of	toxic	species	such	as	oxygen	radicals,	and	
for	 complementation	 of	 mtDNA	 and	 mitochondrial	 membrane	 potential	 	 (Chan,	 2012).	








have	 64%	 amino	 acid	 identity:	 both	 possess	 a	 GTPase	 domain	 at	 the	 N-terminus,	 a	
transmembrane	domain,	and	two	predicted	heptad	repeats	that	are	postulated	to	mediate	
tethering	 between	 adjacent	 mitochondria	 (Pernas	 and	 Scorrano,	 2015).	 However,	 their	
function	is	only	partially	redundant,	as	Mfn2	in	particular	possesses	some	specialized	roles	in	
ER-mitochondria	 tethering	 and	 mitochondria	 motility	 (Labbé	 et	 al.,	 2014);	 this	 is	 also	
reflected	by	 the	differences	 in	 tissue-specific	expression	of	 the	 two	genes,	and	by	 the	 fact	
that	Mfn1,	but	not	Mfn2,	can	complement	certain	pathogenic	mutations	 in	Mfn2	 (Detmer	
and	Chan,	2007).	
They	 form	homo-	 or	 heterodimers	 in	 trans	 to	 tether	mitochondrial	membranes	 and	 bring	
them	 into	 close	proximity.	 The	exact	mechanisms	of	membrane	 fusion	have	not	 yet	 been	
elucidated,	but	they	are	postulated	to	involve	lipid	mixing:	one	candidate	for	this	process	in	
mammals	is	MitoPLD,	which	converts	cardiolipin	to	phosphatidic	acid	(Choi	et	al.,	2006).	
The	 fusion	 of	 the	 IMM	 is	 controlled	 by	 Opa1,	 which	 undergoes	 alternative	 splicing	 and	









Cristae	 can	 display	 different	 morphologies	 with	 regards	 to	 both	 number	 and	 size.	 For	
instance,	treating	cells	with	a	non-glycolytic	substrate	causes	an	 increase	 in	the	number	of	
mitochondrial	 cristae,	 which	 is	 paralleled	 by	 increased	 supercomplexes	 assembly	 and	
respiratory	 capacity	 (Cogliati	 et	 al.,	 2013;	 Rossignol	 et	 al.,	 2004).	 In	 parallel,	 during	





In	 addition	 to	 its	 role	 in	 regulating	 IMM	 fission,	 Opa1	 controls	 cristae	 morphology	 and	
remodeling	(Wong	et	al.,	2000).	The	two	processes	are	actually	independent,	as	interfering	
with	OMM	fusion	does	not	affect	cristae	shape	(Frezza	et	al.,	2006).	The	Opa1	gene	can	be	
alternatively	 spliced	 to	 generate	 8	 different	 isoforms,	 which	 are	 then	 proteolytically	
processed	 by	 two	 groups	 of	 mitochondrial	 proteases:	 AAA	 proteases	 AFG3L2	 and	
paraplegin,	 and	 metalloprotease	 YME1L;	 the	 resulting	 l-Opa1	 cleavage	 products	 can	 be	
further	 processed	 by	OMA1	 or	 rhomboid-like	 protease	 PARL	 to	 generate	 soluble	 s-Opa1	
(Cipolat	 et	 al.,	 2006).	 The	 current	model	 for	 cristae	 structure	 and	maintenance	holds	 that	











Apoptosis	 is	 a	 form	of	 cell	 death	 that	 can	 be	 triggered	 by	 external	 or	 intracellular	 stimuli	
(Kroemer	et	al.,	2009).	The	death	stimuli	converge	on	the	OMM,	where	homo-oligomers	of	
Bcl2	 proteins	 BAX	 and	 BAK	 cause	 OMM	 permeabilization	 via	 the	 formation	 of	 pores	
(Antignani	 and	 Youle,	 2006).	 The	 combination	 of	 cristae	 remodeling	 and	 OMM	
permeabilization	leads	to	the	release	of	cytochrome	c	into	the	cytosol,	where	they	form	the	
apoptosome	with	APAF1	and	caspase	9;	this	initiates	the	apoptotic	cascade	(Li	et	al.,	1997).	
Mitochondrial	 fragmentation	 is	 a	mechanistically	 important	 step	 in	 the	apoptotic	 cascade.	
Indeed,	 increased	 resistance	 to	 apoptosis	 has	 been	 observed	 in	 cells	 deficient	 in	
mitochondrial	fission	(Frank	et	al.,	2001);	a	similar	phenotype	is	present	in	Fis1-knockout	or	
in	Mfn1-overexpressing	cells	(Cassidy-Stone	et	al.,	2008;	Estaquier	and	Arnoult,	2007;	Lee	et	




fragmentation	 by	 excessive	 fission	 or	 decreased	 fusion	 increases	 sensitivity	 to	 apoptotic	
stimuli	 (Leboucher	et	 al.,	 2012;	 Lee	et	 al.,	 2004).	While	 this	does	not	hold	 true	 for	 all	 cell	




cleavage	 of	 l-Opa1	 isoforms	 either	 directly	 by	 pro-apoptotic	 proteins	 (e.g.	 truncated	 Bid,	











The	 main	 readout	 for	 any	 mitochondrial	 imbalance	 is	 disruption	 of	 the	 electrochemical	
potential	 across	 the	 IMM,	which	 is	 the	 direct	 outcome	 of	 an	 effective	 electron	 transport	
chain.		
	
Alternative	 processing	 of	 Opa1	 is	 one	 of	 the	 switches	 that	 signal	 mitochondrial	 stress.	
Constitutive	Opa1	 processing	 involves	 cleavage	 by	 YME1L,	which	 generates	 both	 l-	 and	 s-
Opa1	 isoforms,	 in	a	regulated	proportion.	Alternative	processing	by	OMA1	is	also	possible,	
but	 OMA1	 undergoes	 constitutive	 degradation	 upon	 mitochondrial	 import	 in	 healthy	
organelles	 (Ehses	 et	 al.,	 2009;	Head	 et	 al.,	 2009).	 A	 decrease	 in	mitochondrial	membrane	
potential	allows	OMA1	to	accumulate	and	to	convert	l-Opa1	isoforms	into	s-Opa1,	resulting	
in	 mitochondrial	 fragmentation	 (Anand	 et	 al.,	 2014).	 Depending	 on	 the	 type	 of	 stress,	 a	









with	 by	 mitochondrial	 proteases	 and	 by	 the	 mtUPR	 (1);	 specific	 damaged	 proteins	 can	 be	 ubiquitylated	 and	
retrotranslocated	to	the	cytosol,	where	they	are	degraded	by	the	proteasome	(2);	patches	of	mitochondrial	damage	can	be	
selectively	 removed	and	 targeted	 to	 lysosomes	 (3);	only	 in	 the	presence	of	high	 levels	of	 stress,	entire	mitochondria	are	
targeted	for	degradation	via	mitophagy	(4)	(Sugiura	et	al.,	2014).	
	
One	 recently	 discovered	 line	 of	 defense	 against	 mitochondrial	 stress	 induced	 by	 protein	
imbalance	is	the	mitochondrial	unfolded	protein	response	(mtUPR).	Originally	identified	in	
the	nematode	C.	 elegans,	mtUPR	exploits	 impaired	protein	 import	 into	mitochondria	 as	 a	




version	 of	 the	 mtUPR	 has	 been	 reported	 in	 cultured	 cells;	 it	 relies	 on	 the	 activation	 of	
transcription	 factor	 CHOP,	 which	 also	 has	 parallel	 roles	 in	 ER-specific	 unfolded	 protein	
response	(see	next	section).	Additionally,	oxidized	OMM	proteins	can	be	ubiquitylated	and	












form	 of	 mitophagy,	 which	 is	 the	 selective	 targeting	 of	 damaged	 mitochondria	 for	




















it	 is	 increasingly	 acknowledged	 that	 a	 complex	 interplay	 among	 cellular	 organelles	 exists.	










showing	 that	 certain	 subdomains	 of	 the	 ER,	 termed	 the	MAMs	 (mitochondria-associated	
membranes)	were	 linked	 to	mitochondria	 (Copeland	 and	Dalton,	 1959);	 however,	 hints	 at	
the	actual	structure	of	the	tether	have	only	been	found	in	recent	years.	In	yeast,	a	tethering	
structure	 termed	ERMES	 (ER-mitochondria	 encounter	 structure)	 has	 been	 described,	with	
important	 roles	 in	mitochondrial	 fission	and	 lipid	 transfer	 (Kornmann	et	al.,	 2009).	Also	 in	




Spang,	 2015).	 Direct	 homologs	 of	 these	 complexes	 have	 not	 yet	 been	 identified	 in	 higher	
eukaryotes;	nevertheless,	other	 tethering	units	have	been	 surfacing	 in	 the	past	 few	years.	
Mfn2	 can	 reside	 in	 the	MAM	 and	 form	 homo-	 or	 heterodimers	with	Mfn1,	 tethering	 the	
MAMs	to	mitochondria	(de	Brito	and	Scorrano,	2008).	A	second	tethering	pair	is	composed	
of	 VAPB	 and	 PTPIP51,	 residing	 respectively	 at	 the	 MAM	 and	 OMM	 (Stoica	 et	 al.,	 2014).	




ER	and	mitochondria:	 (I)	 phospholipid	 synthesis	 and	 transfer;	 (II)	 calcium	signaling;	 (III)	 ER	




The	 role	 for	 the	MAMs	 in	 lipid	metabolism	was	 the	 first	 to	 be	 elucidated	 (Vance,	 1990).	












concentration	 is	 4	 orders	 of	 magnitude	 lower	 in	 the	 cytosol	 (de	 la	 Fuente	 et	 al.,	 2013).	
Within	mitochondria,	 calcium	 is	 important	 to	 regulate	 the	enzymatic	 functions	of	 the	TCA	




IP3R	 (inositol-1,4,5-tris-phosphate-sensitive	 receptor)	 calcium	 channels,	 and	 the	




The	 endoplasmic	 reticulum	 is	 the	 subcellular	 compartment	 where	 most	 secreted	 and	




Walter,	 2007).	 In	 order	 to	 prevent	 ER	 stress	 from	 permanently	 damaging	 the	 cell,	 three	
different	 responses	 are	 in	 place	 to	 regulate	 the	 balance	 between	 ER	 folding	 capacity	 and	
polypeptide	 load;	 collectively,	 they	are	 termed	 the	UPR	 (unfolded	protein	 response).	By	a	
vast	 generalization,	 the	UPR	 is	 initially	 a	 rectifying	 response,	 tuning	 protein	 synthesis	 and	
chaperone	 production	 to	 restore	 correct	 protein	 folding;	 if,	 however,	 the	 stress	 signal	 is	
prolonged,	then	the	same	pathways	can	induce	cell	death	(Hetz	et	al.,	2015).	All	three	arms	
of	 the	UPR	 rely	 on	 ER-resident	 transmembrane	 proteins	 that	 act	 as	 relays:	with	 their	 ER-
luminal	 domain,	 they	 sense	 unfolded	 polypeptides	 and	 chaperone	 (i.e.	 BiP/GRP78)	
depletion;	 this	 causes	 them	 to	 undergo	 conformational	 or	 post-translational	 changes	 that	




named,	 are	 PERK	 (protein	 kinase	 RNA-like	 endoplasmic	 reticulum	 kinase),	 IRE1	





oligomerizes	 and	 auto-phosphorylates,	 becoming	 active.	 P-PERK	 then	 phosphorylates	 eIF2α	 on	 Ser51;	 the	 same	
phosphorylation	can	be	performed	by	GCN2,	PKR	or	HRI.	Phosphorylated	eIF2α	prevents	recycling	of	eIF2	to	its	active	form,	





subunit	of	eukaryotic	 translation	 initiation	 factor	 2α 	 (eIF2α)	 at	 serine	51.	 This	decreases	






open	 reading	 frames	 (uORFs)	 that	 normally	 block	 its	 translation;	 however,	 upon	 eIF2α	




can	also	 lead	 to	eIF2α	phosphorylation	and	ATF4	activation,	which	are	collectively	 termed	
the	integrated	stress	response	(Donnelly	et	al.,	2013;	Wek	et	al.,	2006).		
ATF6	 exists	 as	 an	 inactive	 precursor	 in	 the	 ER	membrane;	 upon	 ER	 stress	 induction,	 it	 is	
translocated	from	the	ER	to	the	Golgi	apparatus,	where	specific	resident	proteases	cleave	it	
twice,	 releasing	 it	 from	 the	membrane.	 This	ATF6f	 (fragment)	 can	 then	 translocate	 to	 the	
nucleus,	 where	 it	 transcribes	 UPR	 target	 genes	 (which	 are	mainly	 responsible	 for	 protein	
folding	and	posttranslational	modifications).	
IRE1	 (inositol-requiring	 protein-1)	 is	 also	 activated	 by	 trans-phosphorylation	 following	
oligomerization.	 Its	activation	gives	 it	 the	ability	to	specifically	cleave	one	particular	mRNA	
(coding	for	XBP-1,	X-box-binding	protein	1),	excising	an	intron	and	leading	to	the	translation	
of	 the	 mature	 and	 more	 stable	 form	 of	 the	 protein.	 XBP-1	 is	 a	 transcription	 factor	 that	
positively	regulates	the	expression	of	genes	related	to	protein	folding,	lipid	synthesis	and	ER-
associated	protein	degradation.	
While	 the	short-term	response	 induced	by	 the	ER	stress	 is	a	general	 repression	of	protein	
synthesis,	the	UPR	is	generally	believed	to	be	a	broader	program	aimed	at	restoring	the	cell’s	
secretion	capacity;	 for	this	reason,	 lipid-synthesizing	pathways	are	also	upregulated	by	the	
UPR,	 with	 the	 aim	 of	 increasing	 ER	 volume	 in	 parallel	 with	 its	 folding	 capacity	 (Ron	 and	
Walter,	2007).	
Another	 aspect	 of	 the	 UPR	 is	 the	 increase	 in	 ER-mitochondria	 contact	 sites;	 the	 resulting	
increase	in	mitochondrial	calcium	concentrations	boosts	the	TCA	cycle	and	makes	more	ATP	
available	for	chaperone-mediated	folding	(Bravo	et	al.,	2012),	to	assist	during	the	rectifying	


















Mitochondria	 are	 also	 liable	 to	 undergo	 non-selective	 autophagy	 in	 the	 case	 of	 nutrient	
starvation;	 in	 the	 initial	phases	of	 the	response,	hyperfusion	of	 the	mitochondrial	network	
can	prevent	their	autophagic	degradation	((Gomes	et	al.,	2011)	and	see	paragraph	1.1.2.1).	




TOM20-positive	 and	 enriched	 in	 oxidized	 proteins;	 their	 formation	 is	 PINK1/parkin-
dependent	and	Drp1-independent	(McLelland	et	al.,	2014;	Soubannier	et	al.,	2012).	They	are	
postulated	 to	 act	 as	 a	 first	 line	 of	 defense	 against	 localized	 oxidative	 insults,	 eliminating	





Peroxisomes	are	 single-membrane	organelles	 responsible	 for	 fatty	acid	β-oxidation,	paired	
with	 the	 degradation	 of	 hydrogen	 peroxide	 (Smith	 and	 Aitchison,	 2013).	 For	 both	 these	
functions,	peroxisomes	have	a	close	relationship	with	mitochondria,	which	generate	reactive	






In	 yeast,	 subpopulations	of	peroxisomes	 localize	 to	 sites	of	ER-mitochondria	 interaction	 in	
response	 to	 certain	 metabolic	 conditions	 (i.e.	 in	 the	 presence	 of	 glucose;	 (Cohen	 et	 al.,	
2014)).	 Interactions	 between	 mitochondria	 and	 peroxisomes	 are	 also	 important	 for	 the	









al.,	 2008).	Vps35	belongs	 to	 the	 retromer	 complex,	 and	mutations	 in	 this	 gene	have	been	
associated	 to	 Alzheimer’s	 (AD)	 and	 Parkinson’s	 (PD)	 disease	 (Vilariño-Güell	 et	 al.,	 2011;	
Zimprich	et	al.,	2011);	of	note,	PD-derived	mutations	in	Vps35	in	dopaminergic	neurons	have	





Lipid	 droplets	 are	 dynamic	 organelles	 that	 store	 neutral	 lipids	 (e.g.	 triacylglycerols)	 and	




reported	 that	 lipid	 droplet-localized	 fatty	 acids	 are	 transported	 into	 mitochondria	 under	
starvation	conditions;	within	mitochondria,	they	are	oxidized	in	a	manner	that	is	dependent	




fail	 to	 distribute	 throughout	 mitochondria	 and	 are	 ultimately	 released	 from	 the	 cell	
(Rambold	et	al.,	2015).	















Live	 cell	 imaging	 has	 revealed	 that	 mitochondria	 can	 undergo	 both	 anterograde	 and	
retrograde	transport,	with	occasional	stalling,	and	they	can	be	tethered	close	to	a	synapse	
(MacAskill	and	Kittler,	2010).	
Anterograde	 mitochondrial	 transport	 depends	 on	 the	 KIF5	 family	 of	 kinesins,	 which	 all	
feature	an	ATPase	motor	domain	at	the	N-terminus	and	a	cargo-binding	C-terminal	domain	
(Hirokawa	 et	 al.,	 1991).	 Retrograde	 transport	 is	 driven	 by	 dynein,	 in	 association	 with	
dynactin	(Pilling	et	al.,	2006).		
Mitochondria	associate	to	both	motor	complexes	via	adaptor	proteins	and	OMM	proteins.	In	
mammals,	 TRAK1	 and	 TRAK2	 (homologous	 to	 Drosophila	 Milton)	 are	 adaptor	 proteins	
bridging	OMM	proteins	Miro1	 and	Miro2	 and	 the	molecular	motors	 (Koutsopoulos	 et	 al.,	
2010).	 Specifically,	 TRAK1	 can	 interact	 with	 both	 kinesin	 and	 dynein,	 while	 TRAK2	
predominantly	binds	the	dynein/dynactin	complex	 (Lin	and	Sheng,	2015).	Miro	 is	an	OMM	
GTPase	with	 two	 EF-hand	 calcium-binding	 domains	 (Fransson	 et	 al.,	 2006).	Other	 adaptor	




kinesin	 motors	 (Cai	 et	 al.,	 2005;	 Su	 et	 al.,	 2004),	 and	 FEZ1,	 which	 mediates	 anterograde	
transport	 of	 mitochondria	 during	 NGF-induced	 neurite	 outgrowth	 in	 vitro	 (Fujita	 et	 al.,	
2007).	
Mitochondrial	 localization	 within	 the	 neuritic	 compartment	 is	 activity-dependent:	 high	
synaptic	activity	causes	a	sustained	calcium	entry,	which	is	sensed	by	the	EF-hand	domains	
of	 Miro1	 and	 Miro2;	 this	 causes	 the	 disassembly	 (or	 the	 inactivation)	 of	 the	
Miro/TRAK/molecular	motor	complexes,	arresting	mitochondria	at	sites	where	synapses	are	
active	(Lin	and	Sheng,	2015).	In	addition,	syntaphilin	is	a	mitochondria-docking	protein	that	
immobilizes	 mitochondria	 in	 axons	 in	 instances	 of	 sustained	 neuronal	 activity	 (Chen	 and	
Sheng,	2013).	
Of	 note,	 Miro	 proteins	 have	 also	 been	 shown	 to	 regulate	 mitochondrial	 morphology	 in	
response	 to	 calcium	 increases:	 at	 resting	 calcium	 concentrations,	 Miro	 favors	 fusion	 by	
inhibiting	Drp1	activity;	conversely,	when	calcium	levels	rise,	Drp1-mediated	mitochondrial	
fragmentation	 is	 initiated	 (Saotome	et	 al.,	 2008).	Accordingly,	our	own	previous	work	and	







diseases	 that	 occur	 primarily	 in	 a	 sporadic	 form,	 studying	 the	 fewer	 familial	 cases	 has	
highlighted	 that	 mitochondria	 and	 related	 pathways	 may	 be	 common	 nodes	 in	 the	
pathogenesis	((Schon	and	Przedborski,	2011)	and	references	therein).	
In	addition	 to	 their	 role	 in	 cellular	bioenergetics,	which	accounts	 for	a	 fraction	of	disease-
causing	mutations	 in	 brain,	mitochondria	 in	 a	 neuron	 are	 crucially	 integrated	 in	 the	 cell’s	
physiology	by	means	of	their	network	dynamics:		
(I) Long,	polarized	neurons	 require	 that	mitochondria	be	efficiently	 transported	 to	
pre-	and	post-synaptic	sites	to	produce	ATP	and	to	buffer	calcium;		





(III) Mitochondrial	 quality	 control	 not	 only	 ensures	 a	 functioning	 ATP-producing	
system,	but	also	prevents	the	accumulation	of	damage,	which	is	more	difficult	for	
postmitotic	cells	to	cope	with	(Schon	and	Przedborski,	2011).	
These	 functions,	 or	 often	 a	 combination	 thereof,	 are	 affected	 in	 a	 number	 of	
neurodegenerative	 conditions	 with	 very	 different	 etiologies.	 This	 is	 in	 addition	 to	 the	
observation	 that	 in	 vitro	 models	 of	 neurodegenerative	 diseases	 present	 with	 a	 very	











cortex	 atrophy	 and	 the	deposition	of	 intracellular	 aggregates	 of	 hyperphosphorylated	Tau	
protein	 (neurofibrillary	 tangles)	 and	 of	 extracellular	 plaques	 of	 amyloid-β 	 peptide	 (Aβ;	
(Vinters,	2015)).	The	pathogenic	mechanism	is	far	from	understood,	with	some	investigators	





defects	 in	 mitochondrial	 trafficking,	 in	 the	 form	 of	 accumulated	 mitochondria	 and	
multilamellar	bodies	 in	axons,	were	detected	(Du	et	al.,	2010;	Pigino	et	al.,	2009;	Stokin	et	
al.,	2005).	This	is	paralleled	by	altered	levels	of	mitochondria-shaping	proteins	together	with	










Tau	 toxicity	 derives	 from	 a	 combination	 of	 its	 hyperphosphorylation	 and	 its	 C-terminal	
cleavage,	which	 result	 in	 its	 aggregation.	Depending	 on	 its	 posttranslational	modifications	
and	 on	 the	 co-expression	 of	 Aβ,	 Tau	 leads	 to	 mitochondrial	 fragmentation	 or	
hyperelongation	 (DuBoff	 et	 al.,	 2012).	Of	note,	 both	 in	Drosophila	 and	 in	mouse	neurons,	
mutant	human	Tau	expression	disrupts	cytoskeletal	dynamics	by	stabilizing	F-actin	 (stable,	
fibrillar	actin).	As	a	result,	Drp1	association	to	the	mitochondria	and	the	subsequent	fission	





Parkinson’s	 disease	 (PD)	 is	 a	 neurodegenerative	 disease	 characterized	 by	 tremors	 and	
difficulties	of	movement,	due	to	 loss	of	dopaminergic	neurons	 in	the	substantia	nigra	pars	
compacta.	 Neuropathological	 aspects	 include	 intracellular	 deposition	 of	 Lewy	 bodies,	
composed	of	α-synuclein	and	other	co-aggregating	proteins	(Haelterman	et	al.,	2014).	
Historically,	PD	has	been	linked	to	a	deficiency	in	mitochondrial	complex	I	activity,	due	to	the	
fact	 that	 exposure	 to	 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	 (MPTP)	 caused	 PD-
mimicking	 syndromes	 in	 drug	 users	 (Langston	 and	 Ballard,	 1983;	 Langston	 et	 al.,	 1983).	
Nevertheless,	studies	have	revealed	a	number	of	different	mitochondria-related	genes	to	be	
mutated	in	the	familial	forms	of	PD.	Among	them,	most	are	related	to	mitochondrial	quality	
control,	 though	 some	 also	 affect	 mitochondrial	 motility;	 therefore,	 PD	 is	 now	 largely	
regarded	as	a	disease	of	mitochondrial	quality	control	(Schon	and	Przedborski,	2011).	
Parkin	 and	 PINK1	 can	 both	 be	 mutated	 in	 recessive	 forms	 of	 familial	 PD,	 leading	 to	








with	complex	 I	defects,	 impaired	DOPA	release	and	synaptic	plasticity	 (Kitada	et	al.,	2007;	
Morais	et	al.,	2009).	Remarkably,	neurotoxicity	 in	 this	model	 is	attenuated	by	 inhibition	of	
mitochondrial	 fission,	 highlighting	 the	 important	 role	 for	 Drp1	 in	 mitochondrial	 quality	
control	pathways	(Rappold	et	al.,	2014).	
Another	 PD-causing	 gene	 is	α-synuclein,	which	when	mutated	 gives	 rise	 to	 an	 autosomal	
dominant	form	of	the	disease;	despite	extensive	studies,	its	physiological	role	is	still	unclear	
(Schon	 and	 Przedborski,	 2011).	 In	 addition	 to	 its	 aggregation	 phenotype,	 a	 role	 for	 α-
synuclein	 in	 the	MAMs	has	 recently	 been	proposed	 (Guardia-Laguarta	 et	 al.,	 2014,	 2015).	
Indeed,	 a	 fraction	 of	 wild-type	 α-synuclein	 resides	 in	 the	 MAMs;	 mutant	 forms	 of	 α-
synuclein	are	strongly	recruited	to	the	MAMs,	which	results	 in	a	decrease	 in	MAM-related	
activities,	 a	 decrease	 in	 ER-mitochondria	 contacts,	 and	 in	 mitochondrial	 fragmentation	
(Guardia-Laguarta	et	al.,	2014).	
DJ-1	 is	 another	 PD-associated	 gene	 with	 implications	 for	mitochondrial	 quality	 control:	 it	
harbors	antioxidant	enzymatic	 activity	 and	 it	modulates	mitochondrial	dynamics	 in	 a	ROS-
dependent	fashion	(Irrcher	et	al.,	2010).	Furthermore,	its	deletion	modulates	mitochondrial	
membrane	 potential	 by	 reducing	 the	 expression	 of	 uncoupling	 proteins	 Ucp4	 and	 Ucp5,	
reducing	 the	 physiological	 state	 of	 “mild	 uncoupling”	 that	would	 attenuate	mitochondrial	
ROS	 production	 (Guzman	 et	 al.,	 2010;	 Kwok	 et	 al.,	 2010;	 Ramsden	 et	 al.,	 2012),	 again	
underlining	a	role	in	mitochondrial	quality	control.	
Finally,	kinase	LRRK2	can	be	mutated	in	dominant	forms	of	PD.	It	has	been	shown	to	interact	
with	 the	 fusion	 and	 fission	 machinery,	 modulating	 mitochondrial	 morphology	 towards	 a	





Huntington’s	 disease	 is	 an	 autosomal	 dominant	 disease	 caused	 by	 a	 CAG	 trinucleotide	






the	 face	 and	 arms,	 culminating	 in	 dementia.	 On	 the	 neuropathological	 level,	 the	 primary	
finding	 is	 the	 loss	 of	 medium-size	 spiny	 neurons	 in	 the	 striatopallidal	 and	 striatonigral	
pathways,	together	with	caudate	nucleus	and	putamen	atrophy.	
















manifest	 with	 trafficking	 impairments	 in	 this	 disease.	 In	 fact,	 both	 anterograde	 and	
retrograde	 transport	 are	 reduced	 in	mouse	models	 of	 ALS	 caused	 by	mutant	 superoxide	
dismutase	1	 (SOD1,	one	of	the	few	known	causative	genes;	(De	Vos	et	al.,	2007;	Shi	et	al.,	










Foremost	 among	 them	 are	 Charcot-Marie-Tooth	 disease,	 Hereditary	 Spastic	 Paraplegias,	
Spinocerebellar	Ataxias	and	Optic	Atrophies.	A	detailed	discussion	of	the	 individual	altered	






In	 addition	 to	 diseases	 in	 which	 mitochondrial	 dynamics	 are	 affected,	 some	 genetic	
conditions	are	directly	due	to	loss	or	mutation	of	mitochondria-shaping	proteins.	Depending	






















One	 specific	 form	 of	 optic	 atrophy,	 which	 is	 alternatively	 termed	 Costeff	 optic	 atrophy	
syndrome	or	type	III	3-methylglutaconic	aciduria,	is	due	to	mutations	in	IMM	protein	OPA3	
(Anikster	et	al.,	2001;	Babbar	and	Sheikh,	2013).	OPA3	mediates	mitochondrial	fission	via	a	
yet	 unidentified	 mechanism	 (Ryu	 et	 al.,	 2010).	 In	 a	 mouse	 model	 carrying	 the	 disease	











2004;	 Züchner,	 1993),	 which	 causes	 a	 peripheral	 motor	 neuropathy,	 sometimes	
accompanied	 by	 proprioceptive	 loss;	 other	 rarer	 symptoms	 include	 optic	 atrophy	 and	
subacute	visual	failure	(Burté	et	al.,	2015).	
Another	 form	of	CMT,	CMT4A,	 is	due	to	 loss-of-function	mutations	 in	ganglioside-induced	
differentiation-associated	 protein	 1	 (GDAP1),	 which	 is	 involved	 in	 mitochondrial	 fission	
























The	 hypothalamus	 is	 composed	 of	 distinct	 nuclei	 regulating	 different	 aspects	 of	 body	
homeostasis,	 from	 sleep/arousal	 to	 feeding	 and	 thermoregulation.	 The	 two	 areas	 that	
control	appetite	and	feeding	are:	
(I) The	ventromedial	hypothalamus	(VMH),	which	is	orexigenic;	




(I) AgRP/NPY	 neurons	 produce	 neurotransmitters	 Agouti-Related	 Peptide	 (AgRP)	
and	 Neuropeptide	 Y	 (NPY),	 as	 well	 as	 γ-aminobutirric	 acid	 (GABA),	 and	 their	
stimulation	is	orexigenic;	
(II) POMC	 neurons	 produce	 precursor	 peptide	 proopiomelanocortin,	 which	 is	 then	














Figure	 1.4	 Melanocortin	 system	 in	 the	 arcuate	 nucleus	 of	 the	 hypothalamus.	 Orexigenic	 NPY–AgRP	 neurons	 and	
anorexigenic	POMC	neurons	send	projections	 to	 the	paraventricular	nucleus.	NPY–AgRP	neurons	also	 inhibit	neighboring	
POMC	cells.	Leptin	activates	POMC	neurons	to	secrete	α-MSH,	which	binds	to	MC4R	and	promotes	satiety.	Leptin	inhibits	


















Another	 important	 element	 in	 the	 control	 of	 feeding	 is	 information	 on	 recently	 ingested	




























Fatty	 acids	are	sensed	by	specific	 subpopulations	of	anorexigenic	neurons,	because	of	 the	
accumulation	 of	 their	 breakdown	metabolites	 malonyl-CoA	 or	 of	 the	 CoA-bound	 form	 of	
long-chain	fatty	acids	(Sandoval	et	al.,	2008).	
























The	basal	metabolic	 rate	 includes	cells’	 intrinsic	ATP-producing	ability	and	fuel	preference,	
indicated	 by	 the	 respiratory	 exchange	 ratio	 (RER:	 carbohydrate	 versus	 fat	 oxidation;	
(Bouchard	and	Tremblay,	1990)).	It	can	be	modified	by	thyroid-derived	T3	and	T4,	which	act	
throughout	 the	 body	 on	 nuclear	 TXR	 receptors	 to	 exert	 their	 effects	 on	metabolism.	 For	
instance,	in	liver,	thyroid	hormone	action	increases	gluconeogenesis;	 in	muscle,	proteolysis	
is	induced	to	provide	amino	acids	for	gluconeogenesis	in	the	liver;	in	adipose	tissue,	lipolysis	
is	 induced	 to	 mobilize	 free	 fatty	 acids,	 which	 are	 then	 taken	 up	 by	 the	 liver	 to	 support	
gluconeogenesis.	 Overall,	 this	 is	 an	 energy-consuming	 effort	 that	 increases	 the	 basal	











et	 al.,	 2013b);	 further	 discussed	 in	 1.2.1.4).	 In	 rodents,	 the	 main	 BAT	 depot	 is	 the	
intrascapular,	while	 in	 humans	 smaller	 depots	 exist	 in	 the	 supraclavicular,	 paraspinal,	 and	
neck	region	(Cypess	et	al.,	2009;	Zingaretti	et	al.,	2009).	
Noradrenergic	sympathetic	 innervation	 is	 the	main	activator	of	BAT	thermogenesis;	brown	
adipocytes	express	the	β3-adrenoreceptor,	which	is	a	G-protein-coupled	receptor	associated	
with	Gαs	 activity	 and	adenylate	 cyclase;	 its	 activation	 causes	an	 intracellular	 rise	 in	 cAMP	
and	the	activation	of	PKA.	This	directly	activates	 lipolysis	and	proliferation,	and	 in	addition	
boosts	BAT	gene	expression	in	order	to	sustain	the	thermogenic	process	(i.e.	mitochondrial	




Ucp1	 function	 is	 heat	 production,	which	 is	 due	 to	 the	mitochondrial	membrane	 potential	
being	 dissipated	 across	 the	 IMM	 (Cannon	 and	 Nedergaard,	 2004).	 Of	 note,	 both	 glucose,	











Stress,	 relayed	 by	 the	 hypothalamus/pituitary/adrenal	 axis,	 can	 also	 affect	 systemic	
metabolism,	 mostly	 through	 its	 final	 circulating	 product	 cortisol	 (in	 rodents,	 the	
predominant	glucocorticoid	is	cortisol’s	precursor,	corticosterone,	which	differs	from	it	by	an	
hydroxyl	group).	
The	 axis	 is	 controlled	 by	 the	 paraventricular	 nucleus	 (PVN)	 of	 the	 hypothalamus,	 which	
releases	corticotropin-releasing	hormone	(CRH)	according	to	daily	circadian	rhythm	or	as	a	
stress	response	(i.e.	the	fight	or	flight	behavior)	overseen	by	the	amygdala.	CRH	stimulates	
the	 release	 of	 ACTH	 (adrenocorticotropic	 hormone),	 another	 cleavage	 product	 of	 POMC,	
from	the	anterior	portion	of	 the	pituitary	gland.	ACTH	has	receptors	 in	 the	 fasciculata	and	
reticularis	 layers	 of	 the	 adrenal	 glands,	 which	 secrete	 cortisol	 into	 the	 bloodstream.	
Circulating	cortisol,	and	to	a	smaller	extent	also	ACTH,	exert	negative	feedback	on	both	CRH	
and	ACTH	synthesis	in	the	hypothalamus	and	pituitary	(Boron	and	Boulpaep,	2009).	
The	metabolic	 effects	 of	 circulating	 cortisol	 include	 an	 increase	 in	 gluconeogenesis	 in	 the	
liver,	proteolysis	in	the	muscle	to	provide	amino	acids	for	hepatic	glucose	synthesis,	and	fat	
mobilization.	This	 results	 in	a	net	 increase	 in	circulating	glucose,	which	 is	available	 to	 face	
















Fgf21,	 the	coreceptor	 is	β-Klotho	 (KLB),	 in	preferential	 complex	with	Fgf	 receptor	FGFR1c,	
and	 with	 a	 lower	 affinity	 with	 FGFR2c,	 FGFR3c	 and	 FGFR4	 (Ding	 et	 al.,	 2012;	 Fisher	 and	
Maratos-Flier,	 2015).	 As	 a	 result,	 KLB	 is	 the	main	 determinant	 of	 the	 tissue	 specificity	 of	
Fgf21	action.	In	mice,	KLB	is	expressed	in	WAT	and	BAT,	liver,	both	exocrine	and	endocrine	
pancreas,	 and	 the	 suprachiasmatic	 and	 paraventricular	 nuclei	 (SCN;	 PVN)	 of	 the	
hypothalamus	 (Bookout	 et	 al.,	 2013;	 Johnson	 et	 al.,	 2009;	Wente	 et	 al.,	 2006;	 Xu	 et	 al.,	
2009).	 Upon	 Fgf21	 binding,	 the	 KLB-FGFR1	 complex	 dimerizes	 and	 auto-phosphorylates,	







Figure	 1.6	 Pleiotropic	 metabolic	 actions	 of	 Fgf21.	 Fgf21	 has	 both	 central	 and	 peripheral	 receptors.	 In	 the	 brain,	 Fgf21	











The	paradigm	of	Fgf21	 induction	 is	 its	hepatic	upregulation	upon	prolonged	 fasting,	which	
acts	 in	 an	 autocrine	manner	 on	 the	 liver	 stimulating	 fatty	 acid	 oxidation,	 ketogenesis	 and	
gluconeogenesis	 via	 PGC1α	 (Potthoff	 et	 al.,	 2009).	 A	 similar	 response	 is	 observed	 under	





is	 independent	 of	 hepatic	 insulin	 receptors	 but	 dependent	 on	BAT	 and	on	WAT	browning	
(Inagaki	et	al.,	2007).	





In	 addition	 to	 the	 response	 to	 a	 short-term	 fast,	 Fgf21	 also	 regulates	body	metabolism	 in	
case	 of	 longer	 stretches	 of	 caloric	 restriction	 (Degirolamo	 et	 al.,	 2016).	 Besides	 the	
aforementioned	effects	on	 lipolysis	 and	ketogenesis,	 Fgf21	 can	also	 lead	 to	a	hibernation-













to	 lipogenesis	 and	 lipolysis	 (Owen	 et	 al.,	 2015).	 Its	 signaling	 in	WAT	 is	 dependent	 on	 its	
induction	 of	 adiponectin,	 and	 some	 aspects	 of	 Fgf21	 biology	 are	 lacking	 in	 adiponectin	
knockout	animals	(Lin	et	al.,	2013).	Furthermore,	Fgf21	in	WAT	acts	 in	a	feed-forward	loop	
with	PPARγ ,	whereby	 PPARγ	 activation	 (for	 instance,	 by	 a	 pharmacological	 agonist	 of	 the	
thiazolidinedione	 family)	 stimulates	 Fgf21	 production	 in	WAT,	 and	 in	 turn	 Fgf21	 stabilizes	
PPARγ	by	preventing	 its	SUMOylation	and	 inactivation	(Dutchak	et	al.,	2012).	Finally,	Fgf21	
signaling	induces	browning	of	WAT	by	upregulating	Ucp1	(Fisher	et	al.,	2012),	though	recent	
work	 has	 shown	 that	 this	 aspect	 of	 Fgf21	 biology	 is	 not	 necessary	 for	 its	weight	 loss	 and	
glucose	homeostasis	improvement	(Samms	et	al.,	2015;	Véniant	et	al.,	2015).	
In	BAT,	Fgf21	induces	Ucp1	expression	and	thermogenesis	by	activating	PGC1α,	STAT3	and	







intracerebroventricular	 Fgf21	 administration	was	 sufficient	 to	 induce	weight	 loss	 in	 obese	
mice	 (Sarruf	 et	 al.,	 2010).	 Indeed,	 Fgf21	 crosses	 the	 blood-brain	 barrier	 and	 exerts	 CNS-




(II) It	 causes	 temporary	 female	 infertility	 by	 suppressing	 vasopressin-kisspeptin	
signaling	in	the	hypothalamus	(Owen	et	al.,	2013);	
(III) It	activates	the	hypothalamus-pituitary-adrenal	axis	by	upregulating	CRH,	leading	
to	 an	 increase	 in	 circulating	 corticosterone;	 in	 turn,	 corticosterone	 increases	





(IV) Also	 via	 CRH,	 it	 activates	 the	 sympathetic	 branch	 of	 the	 autonomic	 nervous	
system,	which	mediates	some	of	its	effects	on	BAT	–	namely,	Ucp1	increase	and	
lipolysis	(Owen	et	al.,	2014).	
Of	 note,	 all	 the	 above	 functions	 are	 lost	 upon	 conditional	 KLB	 knockout	 in	 the	








diabetes	 associated	 with	 obesity	 and	 liver	 disease	 (Kim	 and	 Lee,	 2015).	 However,	 the	








For	 instance,	 muscle	 myopathies	 caused	 by	 primary	 mitochondrial	 defects	 significantly	








expression.	 For	 instance,	 disrupting	 autophagy	 by	 ablating	 Atg7	 (which	 is	 critical	 for	
autophagosome	completion)	 in	either	skeletal	muscle	or	 liver	 resulted	 in	Fgf21	production	
via	 PERK-eIF2α-ATF4	 pathway	 (Kim	 et	 al.,	 2013).	 Likewise,	 mice	 with	 a	 skeletal	 muscle-





It	 is	 now	 believed	 that	 many	 forms	 of	 mitochondrial	 disruption	 in	 muscle	 yield	 Fgf21	






Thus,	 it	 is	 now	 speculated	 that	 mitochondrial	 stress	 in	 skeletal	 muscle	 is	 a	 signal	 for	
generalized	 nutrient	 deficiency,	 and	 is	 conveyed	 systemically	 via	 Fgf21;	 this	 phenomenon	
has	 led	 to	Fgf21	being	 referred	 to	as	a	“mitokine”	 (Kim	et	al.,	2013).	Whether	Fgf21	 is	an	






this	 is	 fundamental	 for	 each	 individual	 cell’s	 survival,	 and	 also	 has	 implications	 for	 the	










The	sensor	 for	 cellular	energy	 is	 the	ATP:ADP/AMP	 ratio,	which	controls	 the	activation	of	
AMP-activated	protein	kinase	(AMPK;	(Carling,	2004)).	AMPK	is	a	heterotrimer	composed	of	
a	catalytic	α	subunit	and	two	regulatory	β	and	γ	subunits.	It	monitors	energy	levels	by	direct	
binding	 to	 ATP,	 ADP	 and	 AMP,	with	 different	 outcomes:	 ADP	 and	 AMP,	 the	 latter	with	 a	
stronger	 effect,	 activate	 the	 kinase	 when	 bound;	 conversely,	 ATP	 keeps	 it	 inactive.	






Another	 form	 of	 nutrient	 stress	 that	 cells	 can	 undergo	 is	 amino	 acid	 deficiency;	 the	
relevance	of	amino	acids	for	the	cell’s	metabolism	is	due	to	their	role	as	building	blocks	not	

















(I) It	 increases	 substrate	 availability	 by	 promoting	 glucose	 uptake	 (i.e.	 by	
upregulating	its	transporter	GLUT4)	and	fatty	acids	uptake;		
(II) It	 promotes	 glycolysis	 by	 phosphorylating	 and	 activating	 6-phosphofructo-2-
kinase,	 which	 synthesizes	 the	 allosteric	 activator	 of	 glycolysis	 rate-limiting	
enzyme	6-phosphofructo-1-kinase	(Marsin	et	al.,	2000);		
(III) It	promotes	mitochondrial	biogenesis	(see	below);	
(IV) It	 inhibits	 anabolic	 pathways,	 including	 gluconeogenesis,	 fatty	 acid	 synthesis,	
protein	synthesis	and	ribosomal	RNA	biogenesis	(Hardie	et	al.,	2012);	
(V) It	 reduces	 glycogen	 synthesis	 by	 phosphorylating	 and	 inhibiting	 glycogen	
synthase	(Yuan	et	al.,	2013).	
AMPK	also	 inhibits	mTORC1,	 by	phosphorylating	both	Raptor	 and	TSC2,	 favoring	 catabolic	
over	anabolic	processes.	
	







major	 consumer	 of	 ATP,	 also	 in	 this	 context	 active	 AMPK	 inhibits	 mTORC1	 to	 decrease	
translation	 (Yuan	et	al.,	2013).	Additionally,	AMPK	directly	 inhibits	 translation	by	acting	on	
eukaryotic	Elongation	Factor	2	(eEF2;	(Browne	et	al.,	2004)).	
In	 parallel,	 GCN2	 activation	 of	 eIF2α	 causes	 a	 global	 translational	 repression	 by	 inhibiting	
translation	initiation	((Wek	et	al.,	2006);	see	also	paragraph	1.1.3.3).	
	
Given	 that	 both	 cell	 growth	 and	 energy	 production	 rely	 on	 mitochondrial	 activity,	




(peroxisome	 proliferator-activated	 receptor-γ	 co-activator	 1α);	 specifically,	 AMPK	




pathways	 is	not	 sufficient,	autophagy	 is	 activated	 to	provide	 recycled	macromolecules	 for	
cell	 survival	 (Yuan	 et	 al.,	 2013).	 The	 process	 of	 autophagy	 entails	 the	 formation	 of	 a	
phagophore,	 which	 is	 controlled	 by	 the	 ULK1	 complex	 regulating	 class	 III	
phosphatidylinositol	 3-kinase	 complex	 (including	 Beclin	 1,	 Atg14(L)/barkor,	 Vps15,	 Vps34,	
and	Ambra1)	at	the	ER;	The	Atg12–Atg5–Atg16L1	complex	subsequently	conjugates	LC3	to	
PE	on	the	phagophore,	favoring	its	elongation	and	closure	(Mizushima	and	Komatsu,	2011).	
mTORC1	 inhibition	 relieves	 the	 block	 on	 autophagy	 imposed	 by	 mTOR-mediated	 ULK1	
phosphorylation.	Additionally,	AMPK	activation	directly	activates	ULK1	and	other	autophagy	
mediators	 (Galluzzi	 et	 al.,	 2014),	 in	 addition	 to	 its	 inhibitory	 action	 on	 mTORC1.	 GCN2	











hyperelongation	 of	 the	 mitochondrial	 network	 to	 maximize	 energy	 production	 efficiency;	
nutrient	excess,	on	the	other	hand,	has	been	reported	to	cause	mitochondrial	fragmentation	






Pancreatic	 β-cells	 gauge	 systemic	 nutrient	 availability	 by	 precisely	 coupling	 nutrient	
oxidation	to	nutrient	availability;	as	a	result,	excess	nutrients	are	oxidized	to	produce	ATP,	
leading	 to	 insulin	 secretion	 (Rutter,	 2001);	 however,	 they	 also	 lead	 to	 increased	 NADH	
production	 and	 oxidative	 stress.	 Indeed,	 in	 cultured	 pancreatic	 β	 cells,	 the	 presence	 of	
excessive	 nutrients	 triggers	 mitochondrial	 fragmentation,	 which	 in	 turn	 renders	 ATP	
production	less	efficient.	In	addition,	mitochondrial	fragmentation	prevents	the	spreading	of	
ROS	generated	from	the	respiratory	chain	(Liesa	and	Shirihai,	2013;	Molina	et	al.,	2009).		
This	 process	 is	 also	 relevant	 in	BAT,	where	 the	excess	 nutrients	 derived	 from	 lipolysis	 are	
converted	to	heat	through	futile	energy	cycling.	On	the	other	hand,	muscle	 is	equipped	to	
produce	ATP	with	high	efficiency,	and	therefore	undergoes	significant	oxidative	stress	upon	
large	 increases	 in	 nutrient	 availability	 (specifically,	 fatty	 acids)	 (Liesa	 and	 Shirihai,	 2013).	





Conversely,	 in	 starvation	 conditions,	 ATP	 production	 must	 become	more	 efficient;	 this	 is	
achieved	 through	mitochondrial	 network	 fusion	 and	 cristae	 remodeling,	 which	 favors	 the	
dimerization	of	ATP	synthase	(Cogliati	et	al.,	2013;	Gomes	et	al.,	2011).	
	
While	 it	 is	 clear	 that	 bioenergetics	 affect	 mitochondrial	 dynamics,	 and	 mechanisms	 have	
been	hypothesized	to	explain	the	morphological	changes	occurring	upon	a	metabolic	switch,	
the	opposite	(i.e.	that	mitochondrial	dynamics	directly	affect	bioenergetics)	has	not	yet	been	
convincingly	 proved.	 Nevertheless,	 numerous	 attempts	 at	 manipulating	 mitochondrial	
morphology	 to	 elicit	 changes	 in	 bioenergetics	 have	 highlighted	 that	 the	 plasticity	 of	
mitochondrial	dynamics	 is	 crucial	 to	 the	 successful	 completion	of	 this	metabolic	 response.	
For	 instance,	muscle	Mfn2	ablation,	which	should	mimic	 the	 response	 to	excess	nutrients,	
actually	 exacerbates	 this	 response,	 indicating	 that	 some	 residual	Mfn2	activity	 is	 essential	
for	 cell	 survival	 upon	 nutrient	 overload	 (Sebastián	 et	 al.,	 2012).	 The	 current	 view	 now	













fusion	 and	 fission	 in	 a	 plethora	 of	 developmental	 processes.	 Indeed,	 both	Mitofusins	 and	
Drp1	are	essential	in	early	development,	and	their	ablation	causes	early	embryonic	lethality	
(Chen	et	al.,	2003;	Wakabayashi	et	al.,	2009).	Conditional	deletion	of	both	Mitofusins	in	the	
heart	 also	 causes	 embryonic	 lethality	 due	 to	 Notch-mediated	 inhibition	 of	 myocardial	
differentiation	(Kasahara	et	al.,	2013).	
	
The	 importance	 of	 mitochondrial	 dynamics	 in	 brain	 is	 evidenced	 by	 the	 primarily	
neurological	phenotypes	of	diseases	of	mitochondria-shaping	proteins.	Indeed,	a	single	case	




fission	 (Shahni	et	al.,	2015).	As	 for	mitochondrial	 fusion,	an	axonal	 form	of	Charcot-Marie-
Tooth	disease	and	autosomal	dominant	optic	 atrophy	 result	 from	mutations	 in	MFN2	and	
OPA1,	respectively	((Alexander	et	al.,	2000;	Bradbury,	2004);	see	also	1.1.4.2).	
This	is	reflected	in	studies	on	animal	models,	where	embryonic	knockout	of	Mfn1,	but	not	of	




Subsequent	 attempts	 to	 ablate	 Drp1	 in	 postnatal	 neurons	 highlighted	 its	 importance	 in	
synapse	 formation	 and	 neuronal	 mitochondrial	 transport	 in	 nigrostriatal	 dopaminergic	
neurons	(Berthet	et	al.,	2014),	in	forebrain	neurons	(Oettinghaus	et	al.,	2016;	Shields	et	al.,	
2015),	and	in	cerebellar	Purkinje	cells	(Kageyama	et	al.,	2012).	Of	note,	neurodegeneration	









that	 regulate	 feeding	 and	 energy	 expenditure	 (Nasrallah	 and	 Horvath,	 2014).	 Specifically,	
Mfn1	 and	 Mfn2	 deletion	 in	 AgRP-NPY	 neurons	 protects	 mice	 from	 diet-induced	 obesity	
(Dietrich	et	al.,	2013);	conversely,	Mfn2	ablation	from	POMC	neurons	causes	morbid	obesity	





displayed	 a	 prominent	 and	 severe	metabolic	 phenotype	 (Oettinghaus	 et	 al.,	 2016),	 in	 this	







Synaptic	 dysfunction,	 memory	 deficits	 and	 hippocampal	 atrophy	 due	 to	 ablation	 of	
mitochondrial	fission	in	adult	forebrain	neurons	
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in	 progressive,	 neuronal	 subtype-specific	 alterations	 of	 mitochondrial	 morphology	 in	 the	
hippocampus	 that	 are	marginally	 responsive	 to	 antioxidant	 treatment.	 Furthermore,	DRP1	
loss	affects	synaptic	 transmission	and	memory	 function.	While	 these	changes	culminate	 in	
hippocampal	atrophy,	they	are	not	sufficient	to	cause	neuronal	cell	death	within	10	weeks	of	
genetic	Drp1	ablation.	














well	 as	 fatty	acids	β-oxidation	and	 regulation	of	 cell	death.	During	 the	past	decade,	 it	has	
become	 increasingly	 clear	 that	 processes	 regulating	 mitochondrial	 morphology	 and	
ultrastructure	are	influenced	by	specific	cellular	requirements	upon	which	mitochondria,	in	a	
precisely	regulated	manner,	undergo	fusion	and	division	events	1.	Maintaining	this	balance	is	
especially	 important	 for	 highly	 energy-consuming,	 polarized	 cells	 such	 as	 neurons,	 where	
single	organellar	units	sprouting	from	the	mitochondrial	network	are	transported	along	the	
cytoskeleton	 into	 dendrites	 and	 spines	 to	 meet	 local	 energy	 requirements	 2.	 In	 addition,	
elaborate	 quality	 control	 mechanisms	 also	 rely	 on	 mitochondrial	 dynamics:	 whereas	
defective	 organelles	 are	 sequestered	 by	 fission,	 enabling	 their	 removal	 from	 the	




6.	 The	 outer	 mitochondrial	 membrane	 mitofusins	 1	 (MFN1)	 and	 2	 (MFN2)	 tether	
mitochondrial	membranes	by	homo-	or	heterodimer	formation	7,	thereby	initiating	fusion	of	
the	organelles,	 a	 process	 that	 also	 involves	 the	 inner	mitochondrial	membrane-associated	
GTPase	 Optic	 Atrophy	 1	 (Opa1)	 8.	 In	 addition,	 MFN2	 also	 mediates	 contacts	 between	
mitochondria	 and	 endoplasmic	 reticulum	 9.	 The	 only	 known	 mammalian	 mitochondrial	
fission	protein,	Dynamin-Related	Protein	1	(Drp1),	translocates	upon	dephosphorylation	by	
calcineurin	 10	 to	 fission	 sites	 where	 it	 binds	 to	mitochondrial	 fission	 factor	 (Mff)	 11.	 Drp1	
translocation	is	preceded	by	ER	membranes	wrapping	around	mitochondria	to	constrict	the	






Genetic	 evidence	 in	mice	 and	 humans	 indicates	 that	mitochondrial	 dynamics	 are	 crucially	
important	 in	 neurons:	 in	 humans,	 a	 sporadic	 dominant	 negative	DRP1	mutation	 caused	 a	
lethal	 syndromic	 defect	 with	 abnormal	 brain	 development	 14;	 similarly,	 constitutive	Drp1	
knockout	 in	 the	mouse	 brain	 leads	 to	 lethal	 neurodevelopmental	 defects	 15,16.	While	 the	
crucial	 role	 of	 Drp1	 during	 brain	 development	 is	 undisputed,	 studies	 on	 Drp1	 function	 in	
postmitotic	 (adult)	 neurons	 are	 scarce;	 likewise,	 Drp1	 ablation	 studies	 in	 primary	 cultures	
have	so	far	failed	to	yield	a	conclusive	picture.	In	vitro,	Drp1	ablation	is	reported	to	lead	to	a	
super-elongated	neuroprotective	17–24	or	an	aggregated	mitochondrial	phenotype	associated	
with	 neurodegeneration15,16,25–27.	 These	 discrepancies	 are	 probably	 due	 to	 different	
experimental	conditions:	neuronal	health	is	indeed	influenced	by	the	onset	and	duration	of	
Drp1	inhibition,	which	varies	considerably	among	the	cited	reports	28,	and	different	types	of	
neuronal	 cultures	 studied	 display	 different	 sensitivity	 to	 Drp1	 inhibition.	 In	 vivo,	 Drp1	
ablation	in	Purkinje	cells	results	in	oxidative	stress	and	neurodegeneration	29	demonstrating	
that	Drp1	is	essential	for	postmitotic	neurons’	health.	In	contrast,	transient	pharmacological	
Drp1	 inhibition	 is	 neuroprotective	 in	 several	 mouse	 ischemia	 models,	 indicating	 that	
temporarily	blocking	mitochondrial	fission	holds	therapeutic	potential	30–32.	
	
To	 elucidate	 the	 consequences	 of	 blocked	 mitochondrial	 fission	 in	 the	 central	 nervous	
system	in	vivo,	we	bypassed	the	critical	role	of	Drp1	during	brain	development	by	generating	
Drp1flx/flx	mice	 15	expressing	 tamoxifen-inducible	Cre	 recombinase	under	 the	control	of	 the	
CaMKIIα	 promoter	 33.	 Upon	 induced	 Drp1	 deletion	 in	 postmitotic	 adult	 mouse	 forebrain	
neurons,	mice	 develop	 progressive,	 neuronal	 subtype-specific	 alterations	 in	mitochondrial	
shape	and	distribution	 in	 the	absence	of	overt	neurodegeneration.	 In	addition,	 respiratory	
capacity,	ATP	content,	 synaptic	 reserve	pool	vesicle	 recruitment	as	well	as	 spatial	working	












in	 the	 Drp1	 gene	 (Drp1flx/flx)	 15	with	mice	 expressing	 a	 gene	 for	 a	 tamoxifen-inducible	 Cre	
recombinase	 fusion	 protein	 under	 the	 control	 of	 the	 CaMKIIα	 promoter	 (Fig.	 3.1A)	 33,	
limiting	recombination	primarily	to	the	forebrain.	Eight-week	old	offspring	of	these	crossings	
were	injected	with	tamoxifen	on	five	consecutive	days	(Drp1	inducibly	deleted	in	the	brain,	
Drp1iΔb/iΔb),	 resulting	 in	maximum	DRP1	depletion	 in	 the	hippocampus	within	14	days	 (Fig.	
3.1B).	 Immunohistochemical	 DRP	 staining	 in	 Drp1iΔb/iΔb	 animals	 4	 weeks	 post-tamoxifen	
injection	 (p.t.i.)	 confirmed	 that	DRP1	was	 lacking	 specifically	 in	hippocampal	 neurons	 (Fig.	








it	 with	 a	 mitochondria-targeted	 yellow	 fluorescent	 protein	 (mtYFP).	 Starting	 at	 day	 3	
following	in	vitro	recombination	(DIV),	mitochondria	progressively	clustered	and	aggregated	
in	 the	 soma.	 Fewer	 organelles	 were	 found	 within	 the	 neurite	 compartment,	 where	
mitochondria	 also	 appeared	 larger	 in	 comparison	 to	 sham-transfected	 controls	 (Fig.	 3.2).	
Comforted	 by	 these	 results,	 we	 moved	 to	 adult	 hippocampal	 neurons	 in	 vivo	 to	 study	
mitochondrial	 morphology	 by	 immunohistochemistry.	 At	 day	 10	 after	 Drp1	 ablation,	
enlarged	 spherical	 mitochondria	 started	 to	 aggregate	 in	 the	 perikarya	 of	 hippocampal	
neurons.	Whereas	10	days	p.t.i.	enlarged	mitochondria	clustered	in	the	perikarya	of	approx.	
only	 5%	 of	 CA1	 neurons,	 in	 the	 dentate	 gyrus	 (DG)	 and	 CA3	 hippocampal	 neurons,	
mitochondrial	morphology	changes	occurred	earlier	after	Drp1	ablation.	Conversely,	4	weeks	




subpopulations,	 mitochondria	 of	 CA3	 pyramidal	 neurons	 appearing	 considerably	 less	










pyramidal	 Drp1iΔb/iΔb	 neurons	 display	 normal	 resting	 membrane	 potential	 and	 action	




t=	 100	 ms)	 was	 similar	 to	 that	 observed	 in	 control	 mice	 (151%,	 n=6,	 p	 =	 0.52),	 again	
indicating	normal	release	probability.	However,	when	synaptic	transmission	was	challenged	
by	 application	 of	 100	 stimuli	 at	 either	 10	 Hz	 or	 100	 Hz,	 frequency-dependent	 fEPSP	
facilitation	was	 significantly	 reduced	 in	Drp1iΔb/iΔb	brain	 slices,	where	 synaptic	 transmission	
also	broke	down	more	rapidly	(Fig.	3.5A-C;	Suppl.	Fig.	3.1D,E).	In	addition,	when	subjected	to	
a	 spontaneous	 alternation	 task	 (a	 behavioral	 assay	 for	 hippocampus-dependent	 working	
memory),	 short-term	 working	 memory	 was	 significantly	 impaired	 in	 Drp1iΔb/iΔb	 mice	
compared	to	their	Drp1flx/flx	littermates	(Fig.	3.5D),	not	because	of	impaired	visual	acuity	and	
olfaction	 (Suppl.	 Fig.	 3.1F,	 G).	 These	 synaptic	 transmission	 deficits	 are	 similar	 to	 those	
observed	 in	 the	 neuromuscular	 junction	 of	 drp1-mutant	 Drosophila	 34,	 which	 were	
attributed	to	a	lack	of	synaptic	ATP.	We	therefore	measured	oxygen	consumption	and	ATP	
levels	 of	 hippocampal	mitochondria,	 and	 found	oxygen	 consumption	 (Fig.	 3.5E)	 as	well	 as	
ATP	content	(Fig.	3.5F)	to	be	reduced	in	Drp1-deficient	samples.	In	addition,	ultrastructural	










Several	 previous	 studies	 indicate	 that	 Drp1	 ablation	 in	 vitro	 causes	 a	 reduction	 in	 the	
number	 of	 dendrites,	 spines,	 and	 synapses	 (reviewed	 by	 28).	 However,	 as	 no	 substantial	
changes	in	dendritic	morphology	were	observed	early	after	Drp1	ablation	(4	weeks	p.t.i.;	Fig.	
3.4A),	we	performed	Golgi	silver	impregnations	on	Drp1iΔb/iΔb	brain	sections	10	weeks	p.t.i..	
Sholl	 analysis	 revealed	 that	 while	 overall	 dendritic	 tree	 morphometry	 was	 unchanged,	
dendrites	were	shorter	 in	Drp1iΔb/iΔb	mice	 (Fig.	3.6A),	which	was	associated	with	decreased	
hippocampal	 volume	 (Fig.	 3.6B).	 In	 contrast,	 cortical	 or	midbrain	 volumes	 did	 not	 change	
significantly	 (Suppl.	 Fig.	 3.1H).	 To	 test	 whether	 this	 hippocampal	 atrophy	 was	 associated	
with	 loss	 of	 spines,	 we	 quantified	 spine	 numbers	 on	 apical	 dendritic	 trees	 of	 Golgi-
impregnated	pyramidal	 CA1	neurons,	 but	 did	 not	 find	 any	difference	 (Fig.	 3.6C).	 Likewise,	
number	of	 synapses,	as	assessed	by	co-localization	of	 fluorescent	 stains	 for	pre-	 (VGLUT2)	
and	 postsynaptic	 (PSD95)	 markers	 in	 confocal	 z-stacks,	 was	 normal	 (Fig.	 3.6D).	 Thus,	 the	
depletion	of	mitochondria	from	presynaptic	hippocampal	neuron	terminals	can	account	for	
the	observed	synaptic	transmission	impairments	and	the	specific	deficits	 in	spatial	working	






We	 next	 verified	 whether	 the	 above-reported	 changes	 caused	 by	 Drp1	 ablation	 in	 the	
hippocampus	 led	 to	 neurodegeneration.	 Hippocampal	 neurons	 were	 qualitatively	 and	
quantitatively	normal	 in	Hematoxylin-Eosin	(H&E)-stained	hippocampal	tissue	sections	(Fig.	
3.7A,B),	 with	 no	 signs	 of	 condensed	 eosinophilic	 neurons,	 chromatinolysis,	 or	 apoptotic	
bodies.	In	addition,	in	situ	TUNEL	did	not	detect	any	evidence	of	increased	cell	death	in	the	




dependent	 on	 ATP	 produced	 by	 oxidative	 phosphorylation	 we	wondered	 how	 they	 could	
compensate	 the	 reduced	 ATP	 production	 (Fig.	 3.5F)	 to	 avoid	 neurodegeneration.	
Comparative	mass	spectrometry	analyses	revealed	that	 levels	of	glycolysis-related	proteins	




While	Drp1	 ablation	 in	 Purkinje	 cells	 29	 is	 accompanied	by	macroautophagy	 inhibition	 and	
reactive	 oxygen	 species	 (ROS)	 accumulation,	 extensive	 TEM	 analyses	 did	 not	 reveal	
significant	 autophagosome	 accumulation	 in	 brain	 sections	 from	 Drp1iΔb/iΔb	mice;	 of	 note,	
these	consisted	mostly	of	double-membrane	structures	measuring	500	nm	(i.e.	too	small	to	
accommodate	 mitochondria;	 Fig	 S2).	 Accordingly,	 comparative	 mass	 spectrometry	 in	
hippocampal	 neurons	 did	 not	 reveal	 significant	 changes	 in	 autophagy-related	 proteins	
including	 p62	 and	 LC3	 (Suppl.	 Table	 2).	 Moreover,	 levels	 of	 ROS	 (measured	 by	 DHR	 and	
MitoSox	 fluorescence	on	 isolated	mitochondria),	 of	 thiobarbituric	 acid-reactive	 substances	
(TBARS),	 indicators	of	 lipid	peroxidation,	as	well	as	of	oxidized	 (vs.	 total)	glutathione	were	
unchanged	 in	 mouse	 brain	 homogenates	 4	 weeks	 p.t.i.	 (Fig.	 3.8A-D).	 Indeed,	 our	
comparative	 mass	 spectrometry	 analyses	 revealed	 that	 11	 out	 of	 48	 detected	 oxidative	
stress-associated	proteins	were	upregulated	in	Drp1iΔb/iΔb	brains	10	weeks	p.t.i.	(Suppl.	Table	
3).	Ten	of	these	proteins	are	regulated	by	the	transcription	factor	nuclear	factor	erythroid	2	
related	 factor	 (NRF2),	 whose	 inhibitor	 KEAP1	 (Kelch-like	 ECH-associated	 protein	 1)	 was	
significantly	 downregulated	 (fold	 change:	 0.38;	 Q:	 0.002;	 Suppl.	 Table	 3).	 Among	
upregulated	 proteins	 we	 identified	 several	 glutathione	 S-transferases,	 participating	 in	
solubilizing	 peroxidized	 lipids	 and	 xenobiotics,	 and	 the	 multidrug	 resistance	 protein	 1A,	
capable	 of	 removing	 toxic	 components	 from	 the	 cytosol.	 In	 contrast,	 cytosolic	 and	
mitochondrial	 thioredoxins,	 NRF2	 target	 genes	 that	 help	 reducing	 oxidized	 protein,	 were	
downregulated.	These	results	 indicate	that	Drp1	ablation	 in	postmitotic	neurons	 leads	to	a	
moderate	activation	of	cellular	antioxidant	systems,	possibly	explaining	why	ROS	levels	were	
not	 increased,	 but	 testifying	 that	 indeed	 also	 in	 forebrain	 neurons	Drp1	 ablation	 leads	 to	





mice	 with	 the	 mitochondrially	 targeted	 antioxidant	 mitoQ	 35	 for	 10	 days	 after	 the	 last	
tamoxifen	 injection	 could	 counteract	 the	 mitochondrial	 morphology	 phenotype.	 MitoQ	
significantly	decreased	mitobulbs	 in	hippocampal	CA1	and	granule	neurons	of	 the	dentate	
gyrus	(Fig.	3.8E).	However,	in	CA3	neurons	transformation	of	mitochondria	into	mitobulbs	is	














In	 order	 to	 bypass	 the	 requirement	 for	 balanced	mitochondrial	 dynamics	 during	 neuronal	
differentiation	 and	 brain	 development	 15,16,	 we	 devised	 a	model	 of	 acute,	 inducible	Drp1	
ablation	 in	 adult	 forebrain	 including	 hippocampal	 neurons.	 Upon	 tamoxifen-induced	Drp1	
ablation	mitochondria	appeared	enlarged	and	perinuclearly	 confined.	These	neurons	were	











Accordingly,	 and	 in	 line	 with	 the	 fact	 that	 defects	 in	 mitochondrial	 fission	 impair	
mitochondrial	 transport	 in	 neurites,	 presynaptic	 mitochondria	 were	 decreased.	 A	 similar	
electrophysiological	 phenotype	 associated	 with	 abnormal	 mitochondrial	 morphology	 was	
observed	 at	 neuromuscular	 junctions	 of	 drp1	 mutant	 flies	 34.	 While	 that	 phenotype	 has	
primarily	been	attributed	to	ATP-dependent	effects	on	reserve	pool	vesicle	recycling	due	to	






A	 predictable	 consequence	 of	 inhibiting	 mitochondrial	 fission	 was	 the	 change	 in	
mitochondrial	 network	 morphology,	 with	 predominantly	 enlarged	 spherical	 mitochondria	




brain	milieu	 to	 keep	 autophagy	 at	 a	minimum	 level,	 even	 under	 stress	 conditions.	 This	 is	




A	possible	explanation	for	this	discrepancy	 is	 that	Purkinje	cells	 represent	an	exceptionally	
large	and	extensively	connected	neuronal	 subtype,	which	might	entail	very	high	metabolic	
activity	 and	 associated	 ROS	 production	 (reviewed	 in	 39),	 all	 of	 which	 could	 contribute	 to	
selective	 vulnerability	 of	 this	 neuronal	 subtype	 under	 certain	 stress	 conditions.	 It	 is	
important	to	note	that	Purkinje	cell	death	in	vivo	started	to	occur	already	at	around	week	9	
after	Drp1	 ablation	 29.	On	 the	other	hand,	 in	 line	with	 the	absence	of	oxidative	 stress,	 no	
neurodegeneration	was	observed	upon	10-week-long	Drp1	ablation	in	the	hippocampus,	the	
time	 frame	 when	 Drp1iΔb/iΔb	 animals	 had	 to	 be	 sacrificed	 due	 to	 profound	 systemic-level	







Additionally,	 it	 is	 worth	 noting	 that	 murine	 Purkinje	 neuron	 differentiation	 continues	
throughout	 the	 first	 three	weeks	 of	 life	 40,	 the	 time	when	 the	 L7/pcp2	 promoter	 used	 by	
Kageyama	 et	 al.	 starts	 to	 be	 active.	 It	may	 therefore	 be	 speculated	 that	Drp1	 ablation	 in	
these	neurons	may	still	overlap	with	the	final	stages	of	murine	cerebellar	development	and	
thus	also	contribute	to	the	observed	Purkinje	cell	degeneration.	We	can	conversely	exclude	
neurodevelopmental	defects	 caused	by	Drp1	 ablation	 in	our	model,	as	 recombination	was	
induced	at	the	age	of	8	weeks	and	dendritic	tree	morphology	as	well	as	synapse	and	spine	
numbers	were	unaffected.	Of	note,	a	recent	study	reporting	neurodegeneration	upon	Drp1	
ablation	 in	 postmitotic	 dopaminergic	 neurons	 supports	 the	 notion	 that	 sensitivity	 to	Drp1	
ablation	is	neuronal	subtype-dependent	41.	
	
Collectively,	 our	 results	 indicate	 that	 adult	 hippocampal	 neurons	 cope	 with	 profound	
impairment	of	mitochondrial	dynamics	and	function	by	activating	antioxidant	and	metabolic	
compensatory	 mechanisms.	 Predictably,	 certain	 neuronal	 functions,	 such	 as	 synaptic	
transmission,	can	be	affected	due	to	depletion	of	the	organelles	from	presynaptic	terminals,	














Drp1flx/flx	mice	 15	were	 crossed	 with	 CaMKIIα	 CreERT2	 (Cre+)	 animals,	 obtained	 from	 the	
European	Mouse	Mutant	Archive	 (EMMA	strain	02125)	 33.	At	8	weeks	of	age	 the	 resulting	












inverted	 Zeiss	Axiovert	 200M	 LSM	510	Meta	 confocal	microscope	with	 a	 100x/1.4	Oil	DIC	
objective	using	Enterprise	405	nm	and	Argon	488	nm	lasers.	Z-stacks	were	projected	onto	a	
single	plane	using	ImageJ.	Synapse	numbers	were	quantified	as	described	previously	42.	Golgi	




sections	 applying	 the	 Cavalieri	 principle.	 For	 cortical	 and	 midbrain	 volume,	 only	 sections	






Semithin	 sections	 of	 osmium-stained	 hippocampi	 were	 prepared	 in	 order	 to	 identify	









Transverse	 350	 to	 400	 µm-thick	 hippocampal	 brain	 slices	 were	 cut	 in	 a	 sucrose-based	
solution.	 During	 electrophysiological	 recordings,	 slices	 were	 continuously	 superfused	 with	
artificial	 cerebrospinal	 fluid	 maintained	 at	 32-33°C.	 During	 whole-cell	 patch-clamp	
recordings,	 hippocampal	 CA1	 pyramidal	 neurons	 were	 filled	 with	 biocytin	 for	 subsequent	
morphological	 evaluation.	 Field	 excitatory	 postsynaptic	 potentials	 (fEPSP)	 were	 recorded	






Visual	performance	was	 tested	 in	 the	Morris	Water	 tank	with	a	visible	platform.	Olfaction	







membranes	 using	 the	 iBlot	 Dry	 Blotting	 System	 (Life	 Technologies),	 and	 probed	 with	 the	








Cortical	 neurons	 from	 Drp1flx/flx	 mice	 were	 prepared	 from	 E16.5	 embryos	 by	modifying	 a	
previously	described	method	 45.	Prior	 to	plating,	 cells	were	electroporated	using	 the	Neon	





Brain	 tissue	 samples	 were	 lysed	 in	 2%	 sodium	 deoxycholate	 (DOC),	 100	 mM	 ammonium	
bicarbonate	 buffer,	 reduced	 with	 5	 mM	 TCEP	 and	 alkylated	 with	 10	 mM	 iodoacetamide.	
Proteins	were	 then	 digested	 by	 incubation	with	 sequencing-grade	modified	 trypsin	 (1/50,	
w/w;	 Promega,	 Madison,	 Wisconsin)	 overnight	 at	 37°C.	 The	 digested	 samples	 were	
subsequently	 labeled	with	 isobaric	 tag	 (TMT	6-plex,	 Thermo	Fisher	 Scientific)	 according	 to	











Using	 the	MASCOT	 algorithm	 (Matrix	 Science,	 Version	 2.4.0),	 the	 resulting	mgf	 files	were	
searched	 against	 a	 decoy	 database	 containing	 normal	 and	 reverse	 sequences	 of	 the	
predicted	SwissProt	entries	of	Mus	musculus	(www.ebi.ac.uk,	release	date	16/05/2012)	and	
commonly	observed	contaminants	(in	total	33,832	sequences	for	Mus	musculus)	generated	









intensities	 in	 the	 experiments	were	 employed	 for	 automated	 quantification	 and	 statically	
analyzed	using	a	modified	version	of	our	in-house	developed	SafeQuant	R	script	47.	In	brief,	
reporter	 ion	 intensities	 were	 corrected	 for	 isotopic	 impurities	 according	 to	 the	
manufacturer’s	 instructions.	 Intensities	 for	 each	 peptide	 and	 protein	 ID	 were	 summed,	






Mitochondria	 were	 isolated	 from	 hippocampus	 as	 previously	 described	 49.	 Oxygen	
consumption	 rate	 was	 measured	 in	 isolated	 mitochondria	 from	 cortex	 and	 hippocampus	
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distribution	 of	 alleles.	 At	 8	 weeks	 of	 age	 animals	 were	 injected	 with	 tamoxifen	 for	 5	
consecutive	days	to	induce	recombination	of	the	floxed	Drp1	locus.	
(B)	Mice	of	the	indicated	genotype	were	sacrificed	at	indicated	time	points	after	tamoxifen	
injection.	 Hippocampal	 lysates	 were	 separated	 by	 SDS-PAGE	 and	 immunoblotted	 using	
indicated	antibodies.	






(A)	 Primary	 cortical	 neurons	 isolated	 from	Drp1flx/flx	 E17	 embryos	were	 co-electroporated	


























(A)	Representative	 field	 excitatory	 postsynaptic	 potentials	 (fEPSP)	 before	 and	 after	 10s	 of	











the	 indicated	 time	 points.	 Data	 represent	 average	 ±SEM	 of	 at	 least	 4	 animals	 whose	
hippocampi	were	pooled;	measurements	performed	with	at	least	6	replicates.	
(F)	 ATP	 content	 of	 isolated	 hippocampal	 mitochondria	 of	 Drp1iΔb/iΔb	 and	 control	 mice	 as	
measured	with	a	bioluminescence	assay.	Data	represent	average	±SEM	of	at	least	4	animals	
whose	hippocampi	were	pooled;	measurements	were	performed	with	at	least	8	replicates.	
(G)	 Synapses	 in	 TEM	 images	 of	 Drp1iΔb/iΔb	 4	 weeks	 p.t.i.	 and	 control	 hippocampi	 were	
screened	for	presynaptic	mitochondria.	Data	represent	average	±SEM	of	at	least	4	animals	of	











weeks	 p.t.i.	 and	 control	 CA1	 pyramidal	 neurons.	 Each	 data	 point	 represents	 number	 of	
intersections	of	 the	dendritic	 tree	with	concentric	perisomatic	rings	of	 increasing	diameter	
(exemplified	by	dashed	circles).	Data	represent	average	±SEM	of	at	least	100	neurons.	
(B)	 Hippocampal	 volume	 was	 recorded	 on	 H&E-stained,	 serial	 coronal	 cross	 sections	 of	
Drp1iΔb/iΔb	animals	 8-weeks	 p.t.i.	 applying	 the	 Cavalieri	 principle.	 For	 cortical	 and	midbrain	





(D)	 Coronal	 cross	 sections	 of	 Drp1iΔb/iΔb	10	weeks	 p.t.i.	 and	 control	 brains	 co-stained	with	
presynaptic	VGLUT2	(green)	and	postsynaptic	marker	PSD95	(red).	A	150µm	x	150µm	x	5µm	
confocal	 image	 stack	 in	 the	 CA1	 stratum	 radiatum	 was	 recorded	 and	 the	 number	 of	
overlapping	puncta	was	determined.	Data	represent	average	±SEM	of	at	 least	5	animals	of	













(C)	 In	 situ	TUNEL	of	 coronal	 cross	 sections	of	 frozen	Drp1iΔb/iΔb	10	weeks	p.t.i.	 and	 control	


















(E)	 Drp1iΔb/iΔb	 animals	 treated	 or	 not	 with	 daily	 mitoQ	 injections	 of	 20	 mg/kg	 i.p.	 were	
sacrificed	 10	 days	 p.t.i..	 and	 coronal	 cross	 sections	 of	 FFPE	 brains	 immunostained	 for	
cytochrome	c	oxidase	subunit	1.	Mitobulbs	of	randomly	selected	areas	within	the	indicated	
hippocampal	subregions	were	quantified.	Scale	bar	10	µm.	Data	represent	average	±SEM	of	











(D)	 Field	 excitatory	 postsynaptic	 potentials	 (fEPSPs)	 were	 recorded	 in	 the	 CA1	 stratum	










(H)	 Cortical	 and	 midbrain	 volumes	 were	 recorded	 on	 H&E-stained,	 serial	 coronal	 cross	
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Figure 1, Oettinghaus et al. 
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Figure 2, Oettinghaus et al. 



















































Figure 3, Oettinghaus et al. 
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Figure 4, Oettinghaus et al. 
























































































































































Figure 5, Oettinghaus et al. 






















































































































Figure 6, Oettinghaus et al. 















































































Figure 7, Oettinghaus et al. 
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Figure 8, Oettinghaus et al. 

















































































































Supplemental Figure 1, Oettinghaus et al. 







Supplemental Figure 2, Oettinghaus et al. 

















































Protein	 Gene	 FC	 Q-Value	
Fructose-bisphosphate	aldolase	A		 Aldoa	 0.55	 0.0084	*	
Brain	protein	44	(mitochondrial	pyruvate	carrier)	 Brp44	 0.71	 0.0344	*	
Phosphoglycerate	mutase	1		 Pgam1	 0.80	 0.0468	*	
L-lactate	dehydrogenase	A	chain		 Ldha	 0.81	 0.1861	
Triosephosphate	isomerase		 Tpi1	PE	 0.82	 0.1000	
6-phosphofructokinase,	liver	type		 Pfkl	 0.85	 0.2662	
Phosphoglycerate	kinase	1		 Pgk1	 0.85	 0.3055	
6-phosphofructokinase	type	C		 Pfkp	 0.89	 0.2499	
Glucose-6-phosphate	isomerase		 Gpi	 0.89	 0.2568	
Alpha-enolase		 Eno1	 0.91	 0.2470	
Glyceraldehyde-3-phosphate	dehydrogenase		 Gapdh	 0.99	 0.8268	
Pyruvate	kinase	isozymes	M1/M2		 Pkm2	 1.00	 0.7776	
L-lactate	dehydrogenase	B	chain		 Ldhb	 1.04	 0.7919	
Solute	carrier	family	2,	facilitated	glucose	transporter	member	3		 Slc2a3	 1.08	 0.2199	
Enolase-phosphatase	E1		 Enoph1	 1.10	 0.4551	
6-phosphofructokinase,	muscle	type		 Pfkm	 1.10	 0.6907	
Bisphosphoglycerate	mutase		 Bpgm	 1.12	 0.9618	
Gamma-enolase		 Eno2	 1.17	 0.3132	
Phosphoglycerate	mutase	2		 Pgam2	 1.21	 0.5752	
Glucose	transporter	1	(GLUT1		 Slc2a1	 1.37	 0.0439	*	
Hexokinase-1		 Hk1	 4.37	 0.0016	*	








Protein	 Gene	 FC	 Q-Value	
Cysteine	protease	ATG4C		 Atg4c	 0.60	 0.0966	
Ragulator	complex	protein	LAMTOR3		 Lamtor3	 0.83	 0.5414	
Rapamycin-insensitive	companion	of	mTOR		 Rictor	 0.86	 0.0617	
Autophagy-related	protein	9A		 Atg9a	 0.87	 0.1119	
Hamartin		 Tsc1	 0.93	 0.8762	
Autophagy-related	protein	2	homolog	A		 Atg2a	 0.94	 0.2891	
Tuberin		 Tsc2	 0.97	 0.8646	
Autophagy-related	protein		 Atg13	 1.03	 0.5822	
Sequestosome	/	p62	 Sqstm1	 1.04	 0.8268	
Cysteine	protease	ATG4B		 Atg4b	 1.07	 0.4169	
Serine/threonine-protein	kinase	mTOR		 Mtor	 1.08	 0.3113	
Ubiquitin-like	modifier-activating	enzyme	ATG7		 Atg7	 1.09	 0.3400	
Autophagy-related	protein	2	homolog	B		 Atg2b	 1.09	 0.4264	
Microtubule-associated	proteins	1A/1B	light	chain	3A		 Map1lc3a	 1.09	 0.1735	
GTP-binding	protein	Rheb		 Rheb	 1.11	 0.5684	
Microtubule-associated	proteins	1A/1B	light	chain	3B	 Map1lc3b	 1.12	 0.2273	
Regulatory-associated	protein	of	mTOR		 Rptor	 1.13	 0.3207	
Ubiquitin-like-conjugating	enzyme	ATG3		 Atg3	 1.16	 0.0729	
Beclin-1		 Becn1	 1.17	 0.0741	
Ubiquitin-like	protein	ATG12		 Atg12	 1.20	 0.1165	
Autophagy-related	protein	16-1		 Atg16l1	 1.23	 0.0892	
Autophagy	protein	5		 Atg5	 1.33	 0.0117	*	







Protein	 Gene	 FC	 Q-Value	
Kelch-like	ECH-associated	protein	1		 Keap1	 0.38	 0.0023	***	
Thioredoxin,	mitochondrial		 Txn2	 0.67	 0.0134	*	
Thioredoxin-dependent	peroxide	reductase,	mitochondrial		 Prdx3	 0.77	 0.0297	*	
Thioredoxin		 Txn	 0.77	 0.0286	*	
Thioredoxin	reductase	2,	mitochondrial		 Txnrd2	 0.77	 0.0964	
Multidrug	resistance-associated	protein	1		 Abcc1	 0.80	 0.5612	
Microsomal	glutathione	S-transferase	3		 Mgst3	 0.80	 0.6265	
6-phosphogluconate	dehydrogenase,	decarboxylating		 Pgd	 0.84	 0.0531	
Sulfiredoxin-1		 Srxn1	 0.85	 0.1128	
Phospholipid	hydroperoxide	glutathione	peroxidase,	mitochondrial		 Gpx4	 0.85	 0.1769	
Flavin	reductase	(NADPH)		 Blvrb	 0.86	 0.3307	
Superoxide	dismutase	[Mn],	mitochondrial		 Sod2	 0.94	 0.5272	
Glutathione	S-transferase	A2		 Gsta2	 0.94	 0.2818	
UTP--glucose-1-phosphate	uridylyltransferase		 Ugp2	 0.98	 0.9543	
Thioredoxin	reductase	1,	cytoplasmic		 Txnrd1	 0.99	 0.9485	
Thioredoxin	reductase	1,	cytoplasmic		 Txnrd1	 0.99	 0.9485	
Peroxiredoxin-2		 Prdx2	 0.99	 0.5531	
Heme	oxygenase	2		 Hmox2	 1.01	 0.7210	
Sequestosome-1		 Sqstm1	 1.04	 0.8268	
Glutathione	S-transferase	A4		 Gsta4	 1.04	 0.4437	
4-trimethylaminobutyraldehyde	dehydrogenase		 Aldh9a1	 1.07	 0.3152	
Peroxiredoxin-1		 Prdx1	 1.10	 0.5576	
Glutathione	synthetase		 Gss	 1.11	 0.1446	
Glutamate--cysteine	ligase	regulatory	subunit		 Gclm	 1.12	 0.1312	
Glutathione	peroxidase	1		 Gpx1	 1.12	 0.6620	
Retinal	dehydrogenase	1		 Aldh1a1	 1.12	 0.2235	
Glutathione	reductase,	mitochondrial		 Gsr	 1.13	 0.5022	
Transketolase		 Tkt	 1.14	 0.1258	
Glutathione	S-transferase	P	1		 Gstp1	 1.14	 0.2150	
NAD(P)H	dehydrogenase	[quinone]	1		 Nqo1	 1.15	 0.1912	
Pirin		 Pir	 1.16	 0.3966	
Superoxide	dismutase	[Cu-Zn]		 Sod1	 1.18	 0.1725	
Glucose-6-phosphate	1-dehydrogenase	X		 G6pdx	 1.21	 0.0806	
Glutathione	S-transferase	kappa	1		 Gstk1	 1.26	 0.0532	
Fatty	aldehyde	dehydrogenase		 Aldh3a2	 1.27	 0.0375	*	
Catalase		 Cat	 1.29	 0.0514	
Glutathione	S-transferase	Mu	2		 Gstm2	 1.31	 0.1557	
Glutamate--cysteine	ligase	catalytic	subunit		 Gclc	 1.32	 0.0200	*	
Glutathione	S-transferase	Mu	5		 Gstm5	 1.36	 0.0139	*	
Glutathione	S-transferase	theta-1		 Gstt1	 1.38	 0.0724		
Multidrug	resistance	protein	1A		 Abcb1a	 1.39	 0.0216	*	
Epoxide	hydrolase	1		 Ephx1	 1.39	 0.0081	**	
Glutathione	S-transferase	Mu	7		 Gstm7	 1.40	 0.0324	*	
Beta-glucuronidase		 Gusb	 1.42	 0.0552	*	
Peroxiredoxin-4		 Prdx4	 1.44	 0.0132	*	




Glutathione	S-transferase	omega-1		 Gsto1	 1.51	 0.0067	**	
Glutathione	S-transferase	Mu	1		 Gstm1	 2.00	 0.0120	*	





















Mitochondria	 were	 isolated	 from	 freshly	 harvested	 hippocampus	 of	 Drp1flx/flx	 Cre+	 and	
control	 mice	 4	 weeks	 PTI,	 with	 the	 protocol	 described	 in	 Oettinghaus	 et	 al.,	 2016	
(Manuscript	section).	 Isolated	mitochondria	were	loaded	with	TMRM	and	R123	fluorescent	





Mitochondria	 were	 isolated	 from	 freshly-harvested	 hippocampi	 with	 a	 magnetic	 beads	
isolation	 kit	 (Miltenyi	Biotec),	 according	 to	manufacturer’s	 instructions.	 100	µg	of	 isolated	
mitochondria	(as	measured	by		total	mitochondrial	protein)	were	used.	








































For	 the	 glucose/pyruvate	 tolerance	 test,	 mice	 9	 weeks	 PTI	 were	 starved	 overnight	 and	
injected	i.p.	with	2g/kg	glucose.	Blood	glucose	was	monitored	from	the	tail	vein	using	Accu	







Antibodies	 used	 were	 Drp1	 (BD	 Biosciences,	 611112),	 ATF4	 (Santa	 Cruz,	 sc-200),	 Bip	 (BD	
Biosciences,	610978),	eIF2α	total	(Cell	Signaling,	5324),	eIF2α	P51	(Cell	Signaling	3398),	Akt1	
(Cell	 Signaling,	 9272),	 Akt1-P	 S473	 (Cell	 Signaling,	 4060),	 actin	 (Thermo	 Scientific;	 MA1-
91399),	Ucp1	(Abcam,	ab10983),	Hsp60	(ADI-SPA-807-E,	Enzo).	
Secondary	 antibodies	 were	 anti	 mouse-HRP	 (GE	 Healthcare;	 NA931)	 and	 anti	 rabbit	 (GE	






ELISA	 were	 performed	 on	 either	 serum	 or	 plasma	 samples,	 according	 to	 manufacturer’s	
instructions.	For	metabolic	hormones,	blood	was	collected	in	the	morning	between	9-10	AM	
by	tail	vein	or	heart	puncture.	
The	 following	 assays	 were	 used:	 serum	 Corticosterone:	 (Arbor	 Assays;	 K014-H1),	 T4	
(Callbiotech;	 t4044T-100),	 Leptin	 (BioVendor,	 RD291001200R),	 active	 Ghrelin	 (Millipore,	
EZRGRA-90K),	 Fgf21	 (BioVendor;	 RD291108200R),	 CRH	 (MBS727471,	 mybiosource),	 ACTH	







Organs	 were	 collected	 from	 PBS-perfused	 mice	 and	 RNA	 was	 isolated	 using	 Qiagen	 kits	
(RNeasy	 Lipid	 Tissue	 Kit	 for	 adipose	 tissue;	 74804,	 RNeasy	 Fibrous	 Tissue	 kit	 for	 muscle;	
74704;	RNeasy	kit	for	other	organs	74104).	Reverse-Transcription	was	performed	using	the	
High-Capacity	cDNA	Reverse	Transcription	Kit	 (Invitrogen;	4368814).	Quantitative	real-time	
PCR	was	 performed	 using	 TaqMan	 assays	 (Life	 Technologies)	 on	 a	 7900HT	 Real-Time	 PCR	
System	 (Applied	 Biosystems).	 The	 following	 Taqman	 assays	 were	 used:	 Fgf21	
(Mm00840165_g1),	 18S	 (Mm03928990_g1),	 CHOP	 (Mm01135937_g1),	 PPARα	
(m00440939_m1),	 PPARδ	 (Mm00803184_m1),	 PGC-1α	 (Mm01208835_m1),	 PGC-1β	
(Mm00504720_m1),	 ATF4	 (Mm00515325_g1),	 Akt1	 (Mm01331626_m1),	 PI3K	














Adult	 mice	 (>20g	 body	 weight)	 were	 weighed	 preoperatively	 and	 anesthetized	 with	













drop.	Postoperatively,	mice	 received	a	 subcutaneous	 injection	of	0.5	ml	Ringer	 solution	 to	
compensate	for	intraoperative	fluid	losses,	as	well	as	preventive	analgesia	(0.05	mg/kg	body	
weight	buprenorphine).	
For	 the	half	sympathectomy,	only	 the	nerve	bundle	 innervating	the	right	BAT	was	cut.	For	
sham-operated	mice,	the	entire	procedure	was	reproduced	up	to	the	exposure	of	the	nerve	
bundle,	after	which	tissues	were	repositioned	and	the	mouse	sutured.	












days)	 at	 8	weeks	 after	 birth	 causes	 the	 ablation	 of	 the	Drp1	 gene	 only	 in	 neurons	 of	 the	
forebrain	 (Drp1flx/flx	CaMKIIα::CreERT2;	hereafter,	Drp1flx/flx	Cre+)	 (Figure	5.1	A).	 In	 line	with	
Drp1’s	role	as	a	fission	mediator,	 its	ablation	led	to	a	marked	enlargement	of	hippocampal	
mitochondria,	 which	 appeared	 rounded	 and	 clustered	 around	 neuronal	 nuclei	 already	 4	
weeks	post	tamoxifen	injection	(PTI;	Figure	5.1	B).	This	was	also	confirmed	by	ultrastructural	
analyses,	which	 showed	 that	mitochondria	 of	Drp1-ablated	 neurons	were	 larger,	 rounded	
and	 mostly	 devoid	 of	 cristae	 (Figure	 5.1	 C-E).	 The	 disorganized	 internal	 structure	
notwithstanding,	 mitochondrial	 membrane	 potential,	 as	 measured	 by	 two	 separate	
fluorescent	probes,	TMRM	and	R123	(Tetramethylrhodamine	methylesther	and	Rhodamine	
123),	was	preserved	in	mitochondria	from	hippocampus	4	weeks	PTI	(Figure	5.1	F).	


















a	 lower	 respiratory	exchange	 ratio	 (RER;	Figure	5.2	E),	which	 is	 the	 ratio	of	 the	volume	of	
CO2	produced	to	the	volume	of	O2	consumed.	Complete	oxidation	of	glucose	would	yield	6	
CO2	molecules	for	6	O2	molecules	consumed;	thus,	the	RER	of	an	organism	consuming	only	
glucose	 would	 be	 1.	 Conversely,	 full	 oxidation	 of	 fatty	 acid	 chains	 requires	 more	 oxygen	
molecules	than	 it	 releases	CO2,	and	therefore	β-oxidation	 lowers	the	RER.	 In	this	case,	 the	
lowering	of	the	RER	in	Drp1flx/flx	Cre+	mice	indicates	that	they	have	an	increased	preference	
for	 lipid	β-oxidation	as	fuel	source.	Accordingly,	total	body	fat	mass,	assessed	by	EchoMRI,	
was	decreased	 in	Drp1flx/flx	Cre+	mice	 (Figure	5.2	 F).	 The	 loss	of	 stored	 lipids	 could	also	be	
appreciated	 on	 the	 histological	 level,	 where	 white	 adipose	 tissue	 (WAT)	 presented	 with	
depleted	 fat	 vacuoles,	 and	 brown	 adipose	 tissue	 (BAT)	 ranged	 from	 smaller	 vacuoles	 to	












Finally,	 a	 pyruvate	 tolerance	 test	 (2g/kg	 challenge)	 revealed	 a	 non-significant	 trend	 of	
increase	 in	 hepatic	 gluconeogenesis	 (Figure	 5.3	 C).	 These	 data,	 together	 with	 the	







could	 alter	 fuel	 choice.	 However,	 we	 found	 food	 consumption	 to	 actually	 increase	 in	
Drp1flx/flx	Cre+	mice	 at	 7	 weeks	 PTI;	 only	 at	 the	 pre-terminal	 stages	 of	 the	 phenotype	 did	















A	 plausible	 link	 between	 increased	 corticosterone	 and	 mitochondrial	 defects	 is	 Fgf21,	 a	
circulating	 cytokine	 that	 is	 canonically	 produced	 by	 the	 liver	 and	 WAT	 in	 response	 to	


















mediating	 its	 transcription;	 among	 the	 transcription	 factors	 known	 to	 control	 Fgf21	
expression,	only	ATF4	was	upregulated	 in	Drp1-ablated	brains	 (Figure	5.4	C).	Western	Blot	
analyses	 further	 confirmed	 that	 AKT1,	 one	 of	 the	 candidate	 activators	 of	 Fgf21	 synthesis,	
was	not	phosphorylated	(Figure	5.4	D-E).	
ATF4	 is	 a	 transcription	 factor	 and	 a	 crucial	 node	 in	 the	 integrated	 stress	 response,	which	
responds	to	different	forms	of	stress	via	a	decrease	in	global	translation	and	the	activation	of	
specific	 transcriptional	 programs	 aimed	 at	 damage	 control	 (Donnelly	 2013).	 Eukaryotic	
translation	initiation	factor	2α	(eIF2α)	phosphorylation	is	the	checkpoint	upstream	of	ATF4	
that	regulates	its	expression:	phosphorylated	eIF2α	hampers	binding	of	the	ribosome	to	the	
translation	 initiation	 complex,	 inhibiting	 translation	 of	 most	 mRNAs;	 however,	 ATF4	 and	
other	 stress	 response	 mRNAs	 possess	 upstream	 open	 reading	 frames	 (uORFs)	 that	 allow	
them	to	be	preferentially	translated	only	when	eIF2α	is	phosphorylated.	
Through	 Western	 Blot	 analysis,	 we	 confirmed	 both	 the	 ATF4	 increase	 and	 the	
phosphorylation	of	eIF2α	in	the	hippocampi	of	Drp1flx/flx	Cre+	mice	(Figure	5.4	F-H);	the	same	
pattern	was	observed	for	the	cortex	(data	not	shown).	Furthermore,	canonical	ATF4	target	




ISR.	 PERK	 responds	 to	 ER	 stress,	 in	 the	 form	 of	 misfolded	 proteins.	 General	 Control	
Nonderepressible	 2	 (GCN2)	 is	 a	 sensor	 for	 amino	 acid	 deficiency,	 and	 it	 is	 activated	 by	
uncharged	tRNAs.	PKR	is	activated	by	double-stranded	RNAs,	and	it	signals	viral	infections;	of	









brain	 tissue,	 even	 after	 phospho-protein	 enrichment	 (data	 not	 shown);	 therefore,	 the	










weeks	 PTI,	 and	 remained	 increased	 in	 the	 later	 stages	 of	 the	 phenotype	 (Figure	 5.5	 C-D).	





In	 order	 to	 verify	 the	 contribution	 of	 ER	 stress	 to	 the	 cascade	 that	 results	 in	 Fgf21	
expression,	 we	 treated	 the	 mice	 with	 orally-bioavailable	 chemical	 chaperone	
tauroursodeoxycholic	 acid	 (TUDCA,	 0.4%-supplemented	 chow,	 from	 tamoxifen	 injection	
throughout	 the	phenotype;	 (Lo	et	 al.,	 2013)).	However,	while	 TUDCA	 treatment	did	 lower	
Bip	and	P-eIF2α	levels	in	both	genotypes,	confirming	its	brain	localization	and	activity,	eIF2α	
phosphorylation	 remained	 higher	 in	 TUDCA-treated	 Drp1flx/flx	 Cre+	 mice	 compared	 to	
Drp1flx/flx	 (Figure	 5.6	 A-C).	 Furthermore,	 weight	 monitoring	 showed	 no	 improvement	 of	







antioxidant	 effects,	 we	 chose	 to	 repeat	 the	 rescue	 experiment	 with	 a	 targeted	 PERK	
inhibitor,	GSK2606414	(hereafter,	GSK),	which	has	been	reported	to	decrease	ER	stress	in	a	
mouse	 model	 of	 prion	 disease	 (Moreno	 et	 al.,	 2013).	 In	 addition,	 as	 sustained	 systemic	
inhibition	 of	 the	 ER	 stress	 response	 can	 have	 repercussions	 on	 normal	 physiology,	 we	
treated	mice	7	weeks	PTI	for	5	consecutive	days	(50	mg/kg,	every	12	hours).	Nevertheless,	
weight	 monitoring	 again	 showed	 a	 strong	 negative	 effect	 of	 GSK	 treatment	 on	 mouse	
viability,	with	a	10%	loss	over	less	than	a	week	(Figure	5.6	G).	Indeed,	while	GSK	treatment	
did	 slightly	decrease	eIF2α	 phosphorylation	and	ATF4	 (Figure	5.6	H-K),	 it	 failed	 to	prevent	












mtUPR	 is	 a	 recently-discovered,	mitochondria-specific	 response	 to	 proteotoxic	 stress,	 the	
relevance	 of	which	 has	 so	 far	 only	 been	 demonstrated	 in	 vitro	 in	mammals;	 of	 note,	 the	














we	performed	 total	 proteomics	 analysis	on	pooled	hippocampi	 and	 cortices	 from	mice	10	
weeks	 PTI.	 Analysis	 of	mtUPR-associated	 proteins	 confirmed	 that	 no	mtUPR	 is	 in	 place	 in	





Drp1	ablation	 and	 the	ensuing	energy	defects.	Additionally,	 though	neurons	preferentially	
oxidize	 glucose	 to	 produce	 ATP,	 they	 may	 turn	 to	 alternative	 fuel	 sources	 when	 under	
energetic	 stress.	Total	amino	acid	content	 revealed	 that	while	 the	hippocampus	showed	a	
moderate	 decrease	 in	 amino	 acids,	 they	 were	 significantly	 increased	 in	 the	 cortex	 of	
Drp1flx/flx	Cre+	mice	(Figure	5.7	D).		
In	addition,	among	 the	significantly	different	hits	 in	our	proteomics	analysis,	we	 identified	
aminoacyl-tRNA	 synthetases	 as	 enriched,	with	 a	 remarkable	 distribution:	 80%	 of	 cytosolic	





Finally,	 we	 considered	 heme	metabolism,	 as	 a	 large	 fraction	 of	 the	 biosynthetic	 pathway	
that	 produces	 heme	 resides	 within	 mitochondria,	 and	 it	 exploits	 the	 mitochondrial	
ID	 Protein	 Gene	 FC	 Q-Value	
Q64433	 10	kDa	heat	shock	protein,	mitochondrial	(Hsp10)	 Hspe1	 0.98	 0.6229	









membrane	 potential	 to	 carry	 iron	 atoms	 across	 the	 IMM.	 Indeed,	 coproporphyrinogen-III	
oxidase	 and	 ferrochelatase,	 two	 mitochondria-localized	 components	 of	 the	 heme	
biosynthetic	pathway,	were	downregulated,	as	was	frataxin	(Table	5.2).		
	
ID	 Protein	 Gene	 FC	 Q-Value	
P10518	 Delta-aminolevulinic	acid	dehydratase	 Alad	 1.00	 0.5238	
P22315	 Ferrochelatase,	mitochondrial	 Fech	 0.78	 0.0071	**	





P22907	 Porphobilinogen	deaminase	 Hmbs	 1.06	 0.1691	
P51175	 Protoporphyrinogen	oxidase	 Ppox	 0.91	 0.1215	
Q8CAK1	 Putative	transferase	CAF17	homolog,	mitochondrial	 Iba57	 0.90	 0.0887	
Q9CQN6	 Transmembrane	protein	14C	 Tmem14c	 1.05	 0.4674	
P70697	 Uroporphyrinogen	decarboxylase	 Urod	 0.85	 0.1122	






ID	 Protein	 Gene	 FC	 Q-Value	
P09528	 Ferritin	heavy	chain	 Fth1	 1.27	 0.0409	*	
P29391	 Ferritin	light	chain	1	 Ftl1	 1.04	 0.2494	













Given	the	complexity	of	 the	catabolic	phenotype	caused	by	Drp1	ablation	 in	 the	brain,	we	
sought	to	verify	whether	Fgf21	was	indeed	the	only	mediator	of	the	spectrum	of	metabolic	




Drp1flx/flx	 Fgf21flx/flx	 Cre+	mice	 were	 injected	 with	 tamoxifen	 8	 weeks	 after	 birth,	 and	 their	
progress	monitored.	
Survival	 analysis	 revealed	 no	 significant	 change	 in	 viability	 between	 double	 and	 triple	
transgenics	 (Figure	 5.8	 A).	 On	 the	 other	 hand,	 body	 weight	 was	moderately	 improved	 in	
Drp1flx/flx	Fgf21flx/flx	Cre+	mice	compared	to	Drp1flx/flx	Cre+	mice	(Figure	5.8	B).	



















neurons	 from	 of	 Drp1flx/flx	 and	 Drp1flx/flx	 Cre+	 mice	 4	 weeks	 PTI	 immunostained	 for	
cytochrome	c	oxidase	subunit	1	(green)	and	with	DAPI	(blue).	Scale	bar:	10	μm.	















the	 indicated	 substrates.	 Mal/Glut	 –	 Malate	 and	 Glutamate;	 Oligo	 –	 Oligomycin;	 Rot	 –	
Rotenone;	Duro	–	Duroquinone;	Succ/Rot	–	Succinate	and	Rotenone;	AntiA	–	Antimycin	A;	
Asc	–	Ascorbate.	For	concentrations,	please	refer	to	the	Experimental	Procedures	section.	
Asterisks	 denote	 p	 values	 of	 an	 unpaired,	 two-tailed	 Student’s	 t	 test;	 in	 case	 of	 multiple	













(A)	 Mouse	 viability	 after	 Drp1	 ablation.	 Kaplan-Meier	 plot	 of	 Drp1flx/flx	and	 Drp1flx/flx	Cre+	
mice.	At	least	15	mice	per	group	were	monitored.	












(G-H)	 Histology	 of	WAT	 (G)	 and	 BAT	 (H).	H&E	 staining	of	 FFPE	white	 and	brown	adipose	
tissue	 sections	 of	 Drp1flx/flx	 and	 Drp1flx/flx	 Cre+	 mice	 was	 performed	 10	 weeks	 PTI.	 White	





(J)	 UCP1	 quantification.	 Relative	 intensity	 of	UCP1	 and	 actin	 bands	were	measured.	 Data	
represent	average	±SEM	of	at	least	5	animals.	
Asterisks	 denote	 p	 values	 of	 an	 unpaired,	 two-tailed	 Student’s	 t	 test;	 in	 case	 of	 multiple	












(A)	 Glucose	 tolerance	 test.	 Drp1flx/flx	 and	 Drp1flx/flx	 Cre+	 mice	 10	 weeks	 PTI	 were	 starved	
overnight	and	 injected	with	2	g/kg	glucose,	and	 their	glucose	 levels	were	measured	 in	 tail	
vein	blood	at	the	indicated	time	points.	Data	represent	average	±SEM	of	at	least	7	animals.	
(B)	 Insulin	 tolerance	 test.	 Drp1flx/flx	 and	 Drp1flx/flx	 Cre+	 mice	 10	 weeks	 PTI	 were	 starved	
overnight	and	injected	with	7.5	U/kg	glucose,	and	their	glucose	levels	were	measured	in	tail	
vein	blood	at	the	indicated	time	points.	Data	represent	average	±SEM	of	at	least	5	animals.	




mice	 10	 weeks	 PTI.	 Positive	 control	 represents	 Drp1flx/flx	 mice	 starved	 overnight.	 Data	
represent	average	±SEM	of	at	least	7	animals.	
(E)	 Food	 intake	monitoring.	 Drp1flx/flx	and	Drp1flx/flx	Cre+	mice	were	housed	 in	 single	 cages	
and	 their	 food	 intake	 monitored	 at	 the	 indicated	 time	 point.	 Food	 consumption	 was	
normalized	to	body	weight.	Data	represent	average	±SEM	of	at	least	4	animals.	
(F-G)	 Plasma	 leptin	 (F)	 and	 ghrelin	 (G).	 ELISA	measurement	 of	 plasma	 leptin	 and	 ghrelin	
levels	 in	Drp1flx/flx	and	Drp1flx/flx	Cre+	mice	10	weeks	PTI.	Data	represent	average	±SEM	of	at	
least	4	animals.	
(H-I)	 Serum	 T4	 (H)	 and	 corticosterone	 (I).	 ELISA	 measurement	 of	 serum	 T4	 and	
corticosterone	 levels	 in	Drp1flx/flx	and	Drp1flx/flx	Cre+	mice	at	 the	 indicated	 time	points.	Data	
represent	average	±SEM	of	at	least	4	animals.	
(J-K)	Plasma	CRH	 (J)	 and	ACTH	 (K).	ELISA	measurement	of	plasma	CRH	and	ACTH	levels	 in	
Drp1flx/flx	and	Drp1flx/flx	Cre+	mice	10	weeks	PTI.	Data	 represent	 average	±SEM	of	 at	 least	 4	
animals.	
Asterisks	 denote	 p	 values	 of	 an	 unpaired,	 two-tailed	 Student’s	 t	 test;	 in	 case	 of	 multiple	




















hippocampi	 from	Drp1flx/flx	and	Drp1flx/flx	Cre+	mice	 10	weeks	 PTI	 to	 assay	 for	 transcription	




(E)	 Phospho-AKT	 quantification.	 Relative	 intensity	of	AKT	P473	and	 total	AKT	bands	were	
measured.	Data	represent	average	±SEM	of	at	least	4	animals.	
(F)	 Integrated	 stress	 response	 activation.	 Lysates	 of	 hippocampus	 from	 Drp1flx/flx	 and	
Drp1flx/flx	Cre+	mice	 4	 and	 10	weeks	 PTI	were	 separated	 by	 SDS-PAGE	 and	 immunoblotted	
with	the	indicated	antibodies.	
(G-H)	Phospho-eIF2α 	(G)	and	ATF4	(H)	quantification.	Relative	intensity	of	P-eIF2α	and	total	





Asterisks	 denote	 p	 values	 of	 an	 unpaired,	 two-tailed	 Student’s	 t	 test;	 in	 case	 of	 multiple	

















Drp1flx/flx	Cre+	mice	based	on	 the	 formula	 (4π	 *	Area)/Perimeter2	.	Data	 represent	 average	
±SEM	of	at	least	4	animals	of	which	rER	structures	of	at	least	50	neurons	were	measured.	
(C)	 ER	 stress	 activation.	 Lysates	of	hippocampus	 from	Drp1flx/flx	and	Drp1flx/flx	Cre+	mice	10	
weeks	PTI	were	separated	by	SDS-PAGE	and	immunoblotted	with	the	indicated	antibodies.	
(D)	 Bip	 quantification.	 Relative	 intensity	 of	 Bip	 and	 actin	 bands	 were	 measured.	 Data	
represent	average	±SEM	of	at	least	4	animals.	
Asterisks	 denote	 p	 values	 of	 an	 unpaired,	 two-tailed	 Student’s	 t	 test;	 in	 case	 of	 multiple	














(A)	 ER	 stress	 response	 activation	 after	 TUDCA	 treatment.	 Lysates	 of	 hippocampus	 from	
Drp1flx/flx	 and	 Drp1flx/flx	 Cre+	 mice	 10	 weeks	 PTI	 with	 or	 without	 TUDCA	 treatment	 were	
separated	by	SDS-PAGE	and	immunoblotted	with	the	indicated	antibodies.	







(E)	 Fgf21	 expression	 after	 TUDCA	 treatment.	 qRT-PCR	 analysis	 was	 performed	 on	
hippocampus	 from	 Drp1flx/flx	and	 Drp1flx/flx	Cre+	mice	with	 or	 without	 TUDCA	 treatment	 to	
assay	for	Fgf21	expression	10	weeks	PTI.	Fgf21	ct	values	were	normalized	against	18S	rRNA	
ct	values.	Data	represent	average	±SEM	of	at	least	4	animals.	
(F)	 CHOP	 expression	 after	 TUDCA	 treatment.	 qRT-PCR	 analysis	 was	 performed	 on	













from	 Drp1flx/flx	 and	 Drp1flx/flx	 Cre+	 mice	 with	 or	 without	 GSK	 treatment	 to	 assay	 for	 Fgf21	
expression.	 Fgf21	 ct	 values	 were	 normalized	 against	 18S	 rRNA	 ct	 values.	 Data	 represent	
average	±SEM	of	at	least	4	animals.	
(M)	 CHOP	 expression	 after	 GSK	 treatment.	 qRT-PCR	 analysis	 was	 performed	 on	
hippocampus	from	Drp1flx/flx	and	Drp1flx/flx	Cre+	mice	with	or	without	GSK	treatment	to	assay	
for	 CHOP	 expression.	 CHOP	 ct	 values	 were	 normalized	 against	 18S	 rRNA	 ct	 values.	 Data	
represent	average	±SEM	of	at	least	4	animals.	
Asterisks	 denote	 p	 values	 of	 an	 unpaired,	 two-tailed	 Student’s	 t	 test;	 in	 case	 of	 multiple	


















of	 mtUPR	 proteases.	 mRNA	 ct	 values	 were	 normalized	 against	 18S	 rRNA	 ct	 values.	 Data	
represent	average	±SEM	of	at	least	4	animals.	
(D)	 Free	 amino	 acids.	 Free	 L-amino	 acids	 in	 lysates	 from	 the	 indicated	 brain	 areas	 from	
Drp1flx/flx	and	Drp1flx/flx	Cre+	mice	10	weeks	PTI.	Data	 represent	 average	±SEM	of	 at	 least	 5	
animals.	
(E)	 Aminoacyl	 tRNA	 synthetases.	 Fold	 change	 (Drp1flx/flx	 Cre+	 /	 Drp1flx/flx)	 values	 from	
cytosolic	and	mitochondrial	aminoacyl	tRNA	synthetases	are	plotted	as	a	function	of	their	q-
value	in	the	proteomics	screen.	
Asterisks	 denote	 p	 values	 of	 an	 unpaired,	 two-tailed	 Student’s	 t	 test;	 in	 case	 of	 multiple	



























Asterisks	 denote	 p	 values	 of	 an	 unpaired,	 two-tailed	 Student’s	 t	 test;	 in	 case	 of	 multiple	















This	work	 stems	 from	our	group’s	published	observation	 that	 conditional	Drp1	ablation	 in	
adult	 neurons	 leads	 to	 defects	 in	 neuronal	 function	 and	 long-term	 potentiation	
establishment,	culminating	in	behavioral	alterations	(Oettinghaus	et	al.,	2016).	We	then	set	
out	 to	 complete	 the	 characterization	 of	 the	 neuronal	 phenotype	 of	 Drp1	 ablation,	 and	






Figure	 6.1	Graphical	 abstract.	 Left,	Drp1	ablation	 in	neurons	activates	a	 combination	of	 ISR	branches,	 resulting	 in	Fgf21	
transcription	 by	 Atf4.	 Right,	 Fgf21	 exerts	 a	 paracrine	 action	 on	 its	 hypothalamic	 receptors,	 stimulating	 corticosterone	







In	 accordance	with	 our	 published	 findings	 (Oettinghaus	 et	 al.,	 2016),	mitochondria	 in	 the	





based	 on	 the	 observation	 that,	 according	 to	 our	 proteomics	 screen,	 Drp1flx/flx	 Cre+	 brains	
strongly	upregulate	mitochondrial	uncoupler	Ucp5	(fold	change	1.55,	q	value	0.021).	Little	is	
known	 about	 this	 brain-specific	 uncoupling	 protein:	 recent	 work	 has	 shown	 that	 it	 is	
upregulated	 upon	 oxidative	 insults	 in	 dopaminergic	 neurons	 (Ho	 et	 al.,	 2005),	 and,	
counterintuitively,	 its	 increase	 protects	 MPTP-treated	 neurons	 from	 mitochondrial	
membrane	 potential	 loss	 (Kwok	 et	 al.,	 2010).	 Whether	 Ucp5	 can	 regulate	 mitochondrial	
membrane	potential	 by	modulating	 the	proton	 leak,	 or	whether	 other	mechanisms	 are	 in	
place	 to	explain	 its	activity,	 is	not	yet	clear	 (Cardoso	et	al.,	2014).	On	the	other	hand,	 it	 is	
also	 possible	 that	 the	 mitochondrial	 purification	 protocol	 used	 for	 membrane	 potential	
measurement,	which	is	based	on	sequential	centrifugation	steps,	is	biased	towards	smaller,	
healthier	mitochondria,	 and	 therefore	excludes	 the	extreme	cases	 that	are	 represented	 in	
the	EM	images	(Figure	5.1	C).	
Nevertheless,	the	decreased	activity	of	all	respiratory	complexes	at	10	weeks	PTI	is	a	strong	




10	 weeks	 PTI;	 nevertheless,	 as	 the	mtUPR	 is	 a	 first-line,	 rectifying	 response	 to	misfolded	
proteins,	 it	 is	 possible	 that	 analysis	 of	 earlier	 time	 points	 (2-4	 weeks	 PTI)	 would	 yield	 a	
different	pattern	of	upregulation	of	stress	markers.		
	
Predictably,	 biosynthetic	 activities	 that	 reside	 within	 mitochondria	 show	 some	 degree	 of	




heme	 biosynthesis	 –	 e.g.	 ferrochelatase,	which	 catalyzes	 the	 final	 step	 of	 heme	 assembly	
(Richardson	 et	 al.,	 2010),	 and	 frataxin,	 which	 has	 been	 proposed	 as	 a	 metabolic	 switch	
between	Fe-S	cluster	and	heme	biosynthetic	pathways	(Becker	et	al.,	2002;	Richardson	et	al.,	
2010)	 –	 are	 downregulated;	 conversely,	 iron	 storage	 protein	 ferritin	 is	 upregulated	 in	 the	
cytosol	(Table	5.2	and	5.3).	
In	 light	 of	 the	 fact	 that	 mitochondrial	 iron	 import	 is	 mediated	 by	 specialized	 channel	
mitoferrin	in	a	manner	that	is	membrane-potential-dependent	(Lill	et	al.,	2006;	Shaw	et	al.,	
2006;	Zhang	et	al.,	2005),	a	possible	 scenario	 is	 that	 iron	would	accumulate	 in	 the	cytosol	
because	 it	 is	 unable	 to	 cross	 the	 IMM;	 conversely,	 within	 mitochondria,	 iron-related	
biosynthetic	processes	would	be	halted.	Of	note,	 lack	of	heme	and	Fe-S	prosthetic	groups	
would	negatively	affect	a	plethora	of	respiratory	complex	subunits,	in	which	these	cofactors	









hippocampus	 is	depleted	 (Figure	5.7	D);	of	note,	 amino	acid	 levels	of	Drp1flx/flx	 cortex	and	
hippocampus	 are	 also	 different.	 Remarkably,	 one	 specific	 area	 of	 the	 cortex,	 the	 anterior	
piriform	cortex,	is	the	only	known	sensor	for	amino	acid	limitation	in	the	brain,	and	it	acts	in	
a	GCN2-dependent	manner	to	regulate	feeding	behavior	and	increase	de	novo	biosynthesis	
(Hao	et	al.,	2005).	This	phenomenon	 raises	 the	 interesting	possibility	 that,	 throughout	 the	
brain,	different	responses	are	enacted	upon	Drp1	ablation.	Indeed,	this	aligns	with	existing	







Further	 insight	 into	 the	 biosynthetic	 state	 of	 Drp1-ablated	 brains	 would	 come	 from	 a	
shotgun	metabolomics	 approach	 (currently	 ongoing),	 eventually	 complemented	by	 carbon	
tracing,	which	would	allow	for	the	identification	of	metabolites	and	synthesis	intermediates,	
and	define	a	 clearer	picture	of	 active	metabolic	networks	 (see	 for	 instance	 (Nilsson	et	 al.,	
2014)).	
	
In	 addition	 to	 the	 disruption	 of	 their	 resident	 activities,	 Drp1-ablated	 mitochondria	 also	
affect	 neighboring	 organelles,	 foremost	 among	 them	 the	 ER.	 In	 fact,	 it	 is	 likely	 that	 the	





weeks	 PTI	 (Figure	 5.1	 C).	 Compellingly,	 two	 proteins	 of	 the	 prohibitin	 family	 that	 were	






Compounded	 with	 previous	 reports	 of	 mitochondrial	 dynamics	 being	 tightly	 linked	 to	 ER	
stress,	 these	data	confirm	that,	 like	Mfn2	 (Debattisti	2014,	Diaz	2015,	Schneeberger	2013,	
Munoz	2013,	Ngoh	2012),	also	Drp1	deficiency	results	in	ER	stress.	However,	aside	from	few	
reports	 indicating	 a	 possible	 alternative	 localization	 and	 membrane	 tubulation	 activity	 of	
Drp1	to	the	ER	(Pitts	et	al.,	1999;	Yoon	et	al.,	1998),	there	 is	 little	mechanistic	evidence	of	
how	 Drp1	 deficiency	 would	 mediate	 ER	 stress.	 Analysis	 of	 mitochondrial	 and	 ER	 lipid	








technically	 feasible.	 This	 is	 due	 in	 part	 to	 the	 inabundance	 of	 these	 proteins	 and	 the	
asynchronous	 nature	 of	 their	 activation,	 and	 in	 part	 to	 the	 poor	 performance	 of	 existing	
antisera	(Prof.	David	Ron,	Cambridge,	UK,	personal	communication).	Nevertheless,	although	
we	 lack	 a	 full	 understanding	 of	 the	 combination	 of	 signals	 that	 trigger	 eIF2α	
phosphorylation,	 our	 data	 do	 show	 that	 the	 integrated	 stress	 response	 is	 activated	 in	
Drp1flx/flx	 Cre+	 brains,	 already	 in	 the	 early	 stages	 of	 the	 phenotype.	 Of	 note,	 it	 could	 be	
argued	 that	 the	 observed	 upregulation	 of	 cytosolic	 aminoacyl	 tRNA	 synthetases	 is	 a	
consequence,	 rather	 than	 a	 cause,	 of	 ISR	 activation,	 as	 these	 genes	 are	 transcriptional	
targets	of	ATF4	(Han	et	al.,	2013).	Nevertheless,	the	consensus	in	the	field	is	that	ATF4	does	
not	 always	 transcribe	 the	 full	 range	 of	 its	 target	 genes,	 but	 rather	 functions	 in	 a	
combinatorial	manner	with	other	transcription	factors,	which	determine	the	scope	and	the	
nature	of	the	response	(Kilberg	et	al.,	2009).	
One	 single	 attempt	 at	 a	 pharmacological	 rescue	 with	 recently	 published	 small-molecule	
inhibitor	 of	 P-eIF2α	 ISRIB	 (Sidrauski	 et	 al.,	 2013)	 failed	 to	 decrease	ATF4	 in	Drp1flx/flx	 Cre+	
brains	 (data	 not	 shown);	 thus,	 a	 better	 dose	 titration	 needs	 to	 be	 performed	 to	 ensure	
sufficient	bioavailability	in	the	brain	during	a	long-term	treatment.		
	
ATF4	 is	 a	 transcription	 factor	 that	 binds	 to	 conserved	 CCAAT-enhancer	 binding	 protein-
activating	 transcription	 factor	 response	 elements	 (CARE)	 to	 mediate	 expression	 of	 target	
genes.	 It	does	not,	however,	act	 independently,	but	 it	 is	always	found	in	combination	with	
other	 transcription	 factors	 (e.g.	 members	 of	 the	 C/EBP	 family,	 ATF3);	 thus,	 the	 general	
consensus	is	that	the	combination	of	binding	sites	and	of	the	respective	transcription	factors	
will	 determine	whether	 a	 gene	 is	 expressed	 in	 response	 to	 certain	ATF4-inducing	 stresses	
(Kilberg	et	al.,	2009).	In	our	mouse	model,	Chromatin	ImmunoPrecipitation	(ChIP)	would	be	





brains,	 the	 failure	 of	 two	 separate	 rescue	 approaches	 to	 significantly	 reduce	 the	 ISR	







6.2. Ectopic	 Fgf21	 expression	 in	 Drp1flx/flx	 Cre+	brains	 causes	 a	 systemic	 catabolic	
phenotype	
	





that	 the	 brain	 does	 not	 canonically	 express	 relevant	 levels	 of	 Fgf21	 (Fisher	 and	Maratos-
Flier,	2015;	Suomalainen	et	al.,	2011).	This	raises	a	number	of	interesting	possibilities,	both	




Flier,	2015),	a	prominent	 role	 for	 the	CNS	 in	 the	coordination	of	Fgf21	action	 is	emerging.	
Indeed,	 hypothalamic	 coreceptor	 KLB	 is	 indispensable	 for	 Fgf21	 action,	 and	
intracerebroventricular	(icv)	injection	of	Fgf21	is	sufficient	to	induce	all	associated	metabolic	
alterations	 (Bookout	 et	 al.,	 2013;	 Owen	 et	 al.,	 2014).	 In	 contrast,	 in	 our	model,	 localized	
Fgf21	production	 in	 the	brain	does	not	 recapitulate	all	 the	canonical	 features	of	 increased	
Fgf21	signaling:	specifically,	while	corticosterone	production	and	lipolysis	do	occur,	there	is	




that,	 in	 our	 model,	 Fgf21	 production	 is	 very	 localized,	 and	 its	 presence	 in	 the	 general	
circulation,	 though	 statistically	 significant,	 is	 likely	 negligible,	 since	 it	 is	 one	 order	 of	
magnitude	lower	than	the	canonical	starvation-induced	Fgf21	increase	(Figure	5.4	A).	On	the	









CamK2α	 promoter	 that	 drives	 Cre	 expression	 in	 our	 model	 is	 active	 also	 in	 the	
suprachiasmatic	and	paraventricular	nuclei	of	the	hypothalamus	(Bookout	et	al.,	2013;	Owen	






number	 of	 metabolic	 parameters	 (Degirolamo	 et	 al.,	 2016;	 Kharitonenkov	 and	 DiMarchi,	
2015);	 constitutive	 overexpression	 of	 Fgf21	 is	 even	 associated	 to	 a	 lean	 phenotype	 and	
increased	 longevity	 (Zhang	 et	 al.,	 2012).	 In	 light	 of	 our	 results,	 we	 postulate	 that	 the	
concerted	 action	 of	 the	 central	 and	 peripheral	 Fgf21	 target	 organs	 is	 critical	 for	 the	
metabolism-enhancing	effects	of	Fgf21.	We	believe	that,	in	our	model,	exclusively	activating	
the	 CNS-controlled	 component	 of	 Fgf21	 signaling	 results	 in	 excessive	 catabolism	 and	
lethality.	 Further	 analysis	 of	 organ-specific	 signaling	 pathways	 would	 be	 required	 to	
demonstrate	that	Fgf21-dependent	cascades	are	active	in	the	CNS	but	not	in	the	periphery.	
However,	 to	 conclusively	 demonstrate	 the	 separation	 of	 central	 and	 peripheral	 Fgf21	
signaling,	organ-specific	KLB	knockout	mice	would	be	required.	
	
Two	 aspects	 of	 Fgf21	 physiology	 that	 do	 become	 activated	 in	 our	 model	 system	 are	












phenotype	 in	 our	 mice,	 considering	 that,	 normally,	 pharmacological	 Cushing	 induction	 is	









the	 phenotype.	 Indeed,	 tamoxifen-injected	 Drp1flx/flx	 Fgf21flx/flx	 Cre+	 mice	 have	 decreased,	
but	 not	 completely	 abolished,	 Fgf21	 expression	 (Figure	 5.8	 C),	 which	makes	 it	 difficult	 to	
conclusively	prove	a	 causal	 role	 for	 Fgf21	 in	mediating	 the	phenotype.	As	 it	 is,	we	 cannot	




There	 are	 two	 possible	 explanations	 for	 the	 incomplete	 deletion	 of	 Fgf21	 in	 Drp1flx/flx	
Fgf21flx/flx	Cre+	mice:		
(I) That	Cre	activation	by	tamoxifen	was	not	sufficient	to	recombine	the	Fgf21	locus	
in	 all	 cells	 in	 which	 Drp1	 recombination	 occurred.	 The	 confirmation	 of	 this	
hypothesis	 would	 be	 rather	 laborious,	 as	 one	 could	 not	 accurately	 distinguish	












to	 perform	 single-cell	 RNA-sequencing	 on	 a	 cell	 suspension	 from	Drp1flx/flx	 Cre+	
brains	 (and	 eventually	 on	 triple	 transgenics;	 see	 for	 instance	 (Darmanis	 et	 al.,	
2015;	 Johnson	 et	 al.,	 2015));	 in	 addition	 to	 revealing	 the	 source	 of	 Fgf21,	 this	
experiment	 would	 also	 yield	 further	 insight	 into	 which	 cellular	 responses	 are	





phenotype	 of	 Drp1flx/flx	 Cre+	 mice	 because	 it	 is	 not	 the	 main	 mediator	 of	 the	 systemic	




systemic	 metabolic	 effects,	 foremost	 among	 them	 irisin	 (Boström	 et	 al.,	 2012)	 and	
mitochondria-derived	peptide	MOTS-C	 (Lee	et	 al.,	 2015).	While	 they	did	not	 appear	 to	be	
present	 in	 our	 proteomics	 panel,	 further	 confirmation	 of	 their	 absence	 in	 Drp1flx/flx	 Cre+	
brains	would	strengthen	the	case	for	Fgf21,	as	would	a	full	Fgf21	ablation	in	all	cells.	
	
It	 could	 be	 argued	 that	 sympathetic	 nervous	 system-induced	 lipolysis	 and	 corticosterone	
could	 recapitulate	most	 of	 the	 observed	 phenotype.	 An	 accurate	 approach	 to	 dissect	 the	
relative	contribution	of	each	process	to	the	phenotype	would	be	to	target	them	individually.	
First,	 sympathetic	 nervous	 system	activity	 can	be	 systemically	 attenuated	with	β-blockers,	
which	have	a	well-known	pharmacology	and	are	compatible	with	a	long-term	treatment.	It	is	
important	 to	 note	 that	 broad-range	 β-blockers	 would	 have	 to	 be	 employed,	 in	 order	 to	





Second,	 corticosterone	 synthesis	 can	 be	 blocked	 by	 ketoconazole	 or	 other	 inhibitors	 of	
steroidogenesis,	which	are	currently	used	as	a	treatment	for	Cushing’s	syndrome	(Daniel	and	
Newell-Price,	2015).	
Third,	 the	 sympathetic	 connection	between	 the	brain	and	BAT,	mediating	 lipolysis,	 can	be	
surgically	ablated	(sympathectomy).	This	approach	is	currently	ongoing,	with	the	technique	



















ablates	 BAT	 sympathetic	 innervation	 and	 the	 ensuing	 UCP1-mediated	 thermogenesis.	 (B)	 UCP1	 protein	 levels	 after	 half	
sympathectomy.	The	two	samples	are	derived	from	the	same	mouse,	which	has	undergone	a	half	sympathectomy	and	then	












complements	 a	 body	 of	work	 indicating	Drp1	 blockage	 as	 an	 effective	way	 of	 delaying	 or	
preventing	apoptosis	in	case	of	acute	stress	in	the	CNS	(Estaquier	and	Arnoult,	2007;	Frank	
et	al.,	2001;	Lee	et	al.,	2004;	Li	et	al.,	2015;	Liu	et	al.,	2015a;	Xie	et	al.,	2013),	and	it	poses	the	
caveat	 that	 such	 blockage	 needs	 to	 be	 reversible	 and	 short-term.	 Previous	 work	 had	
primarily	 exploited	 pharmacological	 Drp1	 inhibitor	 mdivi-1	 (Cassidy-Stone	 et	 al.,	 2008);	
whereas	the	results	of	these	studies	were	encouraging,	mdivi-1	suffers	from	a	number	of	off-
target	effects	which	effectively	preclude	its	use	as	a	therapeutic	agent	in	vivo.	In	fact,	mdivi-





One	 promising	 alternative	 to	 pharmacological	 Drp1	 inhibition	 is	 a	 newly-discovered	 Drp1	
peptide	inhibitor,	P110,	which	interferes	with	Drp1	binding	to	its	receptor	Fis1,	and	has	been	





its	 upstream	 phosphatase,	 calcineurin;	 indeed,	 systemic	 and	 skeletal	 muscle-specific	
deletion	of	calcineurin	results	 in	a	hyperelongated	mitochondrial	phenotype	(Pfluger	et	al.,	
2015).	 This	 raises	 the	 possibility	 that	 one	 could	 act	 on	 Drp1	 by	 inhibiting	 its	 activator	
calcineurin,	rather	than	on	Drp1	itself.	
Of	 special	 relevance	 to	 this	 work	 is	 the	 observation	 that	 calcineurin	 ablation	 leads	 to		




Remarkably,	 though	 the	 authors	 state	 that	 neuron-derived	 orphan	 receptor	 1	 (NOR-1)	




as	 a	 universally	 positive	 metabolism-enhancing	 agent,	 can	 actually	 be	 lethal	 when	 its	
bioavailability	 is	 altered.	 This	 hypothesis,	 if	 corroborated	 by	 further	 experiments,	 will	
undoubtedly	 need	 to	 inform	 therapy	 design,	 given	 that	 Fgf21-mimicking	 compounds	 are	
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ADP	 Adenosine	Di-Phosphate	 MFF	 Mitochondria	Fission	Factor	
AFG3L2	 AFG3-Like	AAA	ATPase	2	 MFN	 Mitofusin	









APP	 Amyloid	Precursor	Protein	 MPTP	 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine	





ATG	 Autophagy-related	Gene	 mtUPR	 mitochondrial	UPR	
ATP	 Adenosine	Tri-Phosphate	 NPY	 NeuroPeptide	Y	
BAT	 Brown	Adipose	Tissue	 NTS	 Nucleus	Tractus	Solitarii	



































CJ	 Cristae	Junction	 PKA	 Protein	Kinase	A	
CL	 CardioLipin	 PKC	 Protein	Kinase	C	
CMT	 Charcot-Marie-Tooth	 POMC	 ProOpioMelanoCortin	
CNS	 Central	Nervous	System	 PP2A	 Protein	Phosphatase	2A	








CT	 Cycle	Threshold	 PTPIP51	 Protein	tyrosine	
phosphatase	interacting	
protein	51		






























































GLP1	 Glucagon-Like	Peptide	1	 TRAK	 Trafficking	Kinesin	Protein	
GLUT	 Glucose	Transporter	type	4	 tRNA	 transfer	RNA	
GRP78	 Glucose-Related	Protein	78	 TSC	 Tuberous	Sclerosis	Complex	




HSP	 Heat	Shock	Protein	 UBC1	 Ubiquitin-conjugating	
enzyme	E2	
HTT	 Huntingtin	 UCP	 Uncoupling	Protein	
IBM	 Inner	Boundary	Membrane	 uORF	 upstream	Open	Reading	
Frame	










IRE	 Inositol-Requiring	Enzyme	 VPS35	 Vacuolar	Protein	Sorting	35	
ISR	 Integrated	Stress	Response	 WAT	 White	Adipose	Tissue	
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